Investigation of the Closing Forces Involved in Re-Approximation of the Renal Remnant Following Partial Nephrectomy by Endres, Donald M., II
Grand Valley State University
ScholarWorks@GVSU
Masters Theses Graduate Research and Creative Practice
4-1-2013
Investigation of the Closing Forces Involved in Re-
Approximation of the Renal Remnant Following
Partial Nephrectomy
Donald M. Endres II
Grand Valley State University
Follow this and additional works at: http://scholarworks.gvsu.edu/theses
Part of the Engineering Commons
This Thesis is brought to you for free and open access by the Graduate Research and Creative Practice at ScholarWorks@GVSU. It has been accepted
for inclusion in Masters Theses by an authorized administrator of ScholarWorks@GVSU. For more information, please contact
scholarworks@gvsu.edu.
Recommended Citation
Endres, Donald M. II, "Investigation of the Closing Forces Involved in Re-Approximation of the Renal Remnant Following Partial
Nephrectomy" (2013). Masters Theses. Paper 52.
   
 
 
 
Investigation of the Closing Forces Involved in Re-Approximation of the Renal Remnant 
Following  
Partial Nephrectomy 
 
Donald M Endres II 
 
 
 
 
 
 
 
 
 
A Thesis Submitted to the Graduate Faculty of 
 
GRAND VALLEY STATE UNIVERSITY 
 
In 
 
Partial Fulfillment of the Requirements 
 
For the Degree of 
 
Master of Science in Engineering 
 
 
 
 
Padnos College of Engineering and Computing 
 
 
 
 
 
 
 
 
April 2013  
  
  3 
Dedication 
This thesis is dedicated to all those that have assisted me along the way.  Like nearly all 
significant undertakings, this work would not have been possible without the assistance 
and guidance of many people, at many levels. 
Special recognition is owed to the research team which assisted me in the lab.  The 
skilled hands of Dr. Brian Lane from Spectrum Health were invaluable in preparing and 
testing specimens for suture tension.  He and I both appreciated the knowledge and 
effort Conrad Tobert, who took time from his own medical studies at Michigan State 
University, brought to the lab bench.  Similarly appreciated are the sharp eye, willing 
hands and clear head of Professor Bossemeyer, PhD, Grand Valley State University, 
who made sure we were focused on the objective, stepped in to assist whenever 
needed and made important observations. 
Members of the first Master of Science in Engineering - Biomedical cohort and the 
Biomedical faculty at Grand Valley State University also played an important part in 
making this a successful endeavor.  Unlike universities where students succeed at the 
expense of others, our group worked together to navigate through the first years of a 
new program.  From the discussions of theoretical concepts behind coursework to 
sharing the procedural tips to overcome registration problems, the daily communications 
were critical. 
Most importantly, thanks go to my wife and children who made the time for me to 
participate in this program.  They helped with household tasks on many occasions so 
that I could focus on my studies.    
  4 
Acknowledgements 
The following individuals and organizations have contributed to this work: 
Dr. William Baer, MD, Pharm.D, VARI-Clinxus, LLC was instrumental in bringing the 
research team together.  Without his extensive knowledge of the skills and expertise in 
the Grand Rapids medical community, the research team may have never met. 
Jones Farm Market, LLC of Saranac, Michigan and De Vries Meats, Inc. of 
Coopersville, Michigan both contributed tissue samples.  The staffs at both 
organizations were extremely helpful in getting the samples needed for this research. 
Grand Valley State University and Spectrum Health System contributed to the space 
and supplies necessary for both the fabrication of the tools used in the experiments and 
the research itself. 
The National Science Foundation providing funding through a grant to Prof. Samhita 
Rhodes and Prof. John Farris to establish the new graduate level program at Grand 
Valley State University.  That funding played a major role in financing the first cohort of 
the program. 
  
  5 
Abstract 
Partial nephrectomy has become the preferred method of treatment in certain renal 
diseases, including small, peripheral tumors.  However, re-establishment of hemostasis 
in the remaining tissue remains a challenging procedure.  To better understand the 
forces involved in re-approximation of the renal remnant, this study measures the suture 
tensions reached in sliding clip renorrhaphy, as well as the ability of the tissue to 
support those tensions, and reviews how long suture material might be expected to 
survive those forces. 
Three separate groups of experiments were conducted on fresh, porcine kidney tissue.  
Treatment groups were compared using commercially available software to compute 
appropriate descriptive statistics and generate regression lines. 
Suture tension was measured at 2.8 ± 0.7 Newtons (N) (mean ± standard deviation) in 
ischemic organs, 3.2 ± 0.7 N in kidneys at normal perfusion and 3.4 ± 0.7 N at perfusion 
levels over 200 mm Hg (107 inches H2O). 
Other experiments measured the tension required to cause tissue in both complete 
sutures (terminated on both ends with surgical clips) and half sutures (placed in a 
hemisphere of tissue and terminated with a clip only on the trailing end) to be torn from 
the organ.  Positive relationships were shown between the amount of enclosed tissue 
(margin size) and the tension at failure for both complete and partial sutures.  Margins 
below 1 cm in size failed at levels which could affect their usefulness in closing the 
parenchyma.  Also, a positive correlation between failure tension and angle of applied 
force relative to the capsule surface was observed for angles in the range of 0º to 90º. 
  6 
In a related experiment, different diameter sutures were tested on standard sized 
specimens.  Differences in the force required to cause the suture to cut through the 
samples were not shown in the small sample. 
The tensile strengths of suture material at eight different durations of exposure to select 
environmental conditions were tabulated so that materials appropriate for renorrhaphy 
can be identified.  Tensile strength before and after exposure, size, and environmental 
conditions were listed.  Data indicates that appropriate materials can be selected from 
available suture. 
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Introduction 
Since the advent of solid state electronics in the mid-twentieth century, clinical medicine 
has leveraged new technologies in the diagnosis and treatment of numerous ailments.  
Stable electronic components and digital processors, which can withstand the clinical 
use environment and operate without skilled electronics technicians present, make 
expert systems available to medical professionals in all settings. 
One of the most frequently applied advancements is the use of improved imaging, such 
as computed tomography.  With the innovation of new imaging modalities and three 
dimensional representations, internal medicine has seen an increase in the early 
diagnosis and treatment of many abnormalities.1  Unusual growths can be located and 
identified with minimal impact on the patient.  
The benefits of technology and improved diagnosis have impacted the practice of 
urology as much as any other discipline.  The internist is now able to detect small 
tumors in the kidney at very early stages.  Once a renal tumor is identified, the 
oncologic urologist must determine a course of treatment.  Frequently, the preferred 
treatment plan includes surgical removal of the tumor.  Currently, in an effort to reduce 
the amount of pain during healing and speed recovery, there is emphasis on the use of 
minimally invasive techniques to accomplish removal of renal tumors.  Aided by 
improvements in laparoscopic tools since 1960, a growing number of procedures are 
undertaken using laparoscopic or robot-assisted techniques. 
Also driven by the interest in improving patient outcome, there is a trend toward surgical 
removal of only that renal tissue which has been, or is expected to become, affected by 
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disease.  The previously prevalent use of complete kidney removal is falling into 
disfavor as the consequences are becoming better understood and better methods 
become available.  The result is that, increasingly, the urologist must close the site of a 
tumor resection within a functioning organ.  Methods to achieve hemostasis in the 
remaining tissue have been developed based on practice and techniques used for other 
soft tissues. 
This research attempts to achieve a better understanding of renorrhaphy, the sutured 
closing of a kidney.  The goal is to provide oncologists with information useful to 
improving patient outcome.  Tension in a sutured closure in renal tissue, life expectancy 
of suture material, and tensions causing suture failure are considered.  The intent is to 
provide quantitative estimation of the forces involved in a sutured closure.  A better 
understanding of the relative magnitude of those forces could focus future research 
activities in the area most likely to improve the products and techniques available to 
surgeons. 
Background 
History 
The first successful, intentional, surgical removal of a kidney, now referred to as radical 
nephrectomy (RN) or simply nephrectomy, is thought to have been performed in 1869 
by Gustav Simon in Heidelberg, Germany.2 3  Twenty-one years later in the same clinic, 
partial nephrectomy (PN), which is also known as nephron sparing surgery (NSS), was 
pioneered.4  Laparoscopic-like procedures, where only small openings were made into 
the body cavity, were documented as early as the beginning of the twentieth century for 
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examinations of internal organs. 5 6  However, their use mainly remained the domain of 
gastroenterologists, internists, and gynecologists7 until the latter half of that century 
when the tools and methods to perform other procedures became available.  In their 
1992 article entitled, “Laparoscopic Nephrectomy: A Review of 16 Cases”, Clayman et 
al. reported on the use of laparoscopic procedures for nephrectomies beginning in 
1990, whereby the kidneys were removed through three or four openings less than an 
inch in diameter.8  Early laparoscopic nephrectomies (LNs) were made possible by the 
advent of tissue capture bags and morcellator devices which were capable of efficiently 
cutting and capturing the excised tissue.9  In addition, laparoscopic removal of whole 
kidneys, frequently termed laparoscopic radical nephrectomies (LRNs), overcame 
problems with control of bleeding from large vascular structures via the use of surgical 
staples. 
The feasibility of laparoscopic NSS, wherein only diseased tissue is removed and the 
remainder of the kidney is left intact, was tested in porcine models (swine) the same 
year as Clayman’s article on the first radical nephrectomies and documented the 
following year.10  The first laparoscopic partial nephrectomies (LPNs) in human subjects 
were also performed in 1992 and reported in 1993.11 12  Since 1993, the use of LPN has 
grown steadily in the treatment of small, peripheral tumors.13  Lane et al. found the use 
of LPN in treating small, localized tumors to have moved from 11% of total procedures 
during the period between 1998 and 2002 to 81% between 2010 and 2011.14  
Additionally, more challenging cases are treated laparoscopically as LPN procedures 
more closely mimic proven open methods and robotic devices have become available to 
assist with the manipulation of laparoscopic tools. 
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Modern Urologic Procedures 
Partial nephrectomy, where little more than the dysfunctional portion of the organ is 
resected, is generally accepted to result in better renal function than radical surgeries 
wherein an entire kidney, part of the ureter and possibly surrounding fat, fascia and 
lymph nodes are removed.15  Reports associate NSS with lower overall mortality, lesser 
likelihood of chronic kidney disease, and lower risk of renal failure.16  Furthermore, the 
benefits of LPN over open surgeries have been identified as shorter operative time, 
decreased blood loss, shorter hospital stay, and faster return to normal activity.17  
However, the nature of laparoscopic procedures is that reduced trauma to the patient is 
achieved at the expense of limited intra-operative surgical access and diminished visual 
acuity which results from use of two-dimensional viewing systems and blood in the 
surgical site.  To improve visibility, LPN is generally performed on an ischemic, i.e., 
bloodless, organ.  Ischemia is achieved by occluding blood flow to the kidney in a 
process described as hilar clamping, where a surgical clamp is applied to the hilum. 
Concerns with an ischemic method include the potential for damage to the remnant 
tissue and the inability to provide hypothermic control.18  While ischemia enhances 
visual cues available to the surgeon, it creates a need for urgency in order to prevent 
tissue damage caused by the lack of nutrient flow.  The risk of extended ischemic time 
and subsequent tissue damage is being overcome with new apparatus, modified 
procedures and additional experience, as evidenced by the aforementioned rapid 
increase in the use of the minimally invasive LPN for less complicated cases.  Yet, 
minimally invasive partial nephrectomies (MIPN), whether robot-assisted or not, 
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continue to be considered challenging procedures, particularly during the establishment 
of hemostasis.   
Because of the highly vascular nature of the kidney, a principal concern in MIPN is the 
control of blood loss during and after the surgery.  Excessive bleeding not only impairs 
the physician’s vision, but can also produce hematoma, or the localized pooling of blood 
in tissue outside the vessels, and necessitate remedial procedures post-operatively.  
Consequently, numerous products and methods have been considered in an effort to 
find the optimal means of managing blood loss both intra and post-operatively.  
Products evaluated have included both natural and synthetic hemostatic agents and 
absorbent / hemostatic cloth, as well as tourniquet-like constrictors.19  The hemostatic 
agents represent a major class of products intended to assist in reduction of blood loss.  
These products are intended to promote the containment of blood within the vessels, 
generally by accelerating clotting.  Methods to limit bleeding have included such 
techniques as thermal ablation,20 passing multiple sutures through the organ in a line 
surrounding the resection to constrict blood flow to the area21 and multiple combinations 
of products, with and without suturing.22 
Following resection, the surgical site is closed via one of a number of means.  Current 
protocols for the closure of the renal remnant vary.  Some researchers have reported 
success using hemostatic agents and materials applied without the aid of suturing.23 24 
25  Those successes are generally limited to small resections which are peripheral to the 
collecting system and hilum.  More accepted is renorrhaphy or sutured closure, with or 
without the assistance of a hemostatic product.  One such technique involves the 
placement of absorbable, hemostatic bolsters in the site and re-approximation of the 
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wound with sutures ‘over the bolster’.  Because of the need to reduce warm ischemic 
time and limit the associated risk of tissue damage, as well as the difficulty of 
performing simple surgical procedures through the laparoscopic trocar (as seen in 
Figure 1: Donor Nephrectomy Trocar Placement), sutures are frequently terminated with 
surgical clips rather than knots.  Additionally, severed arteries and collecting ducts are 
frequently clamped with absorbable clips or tied with sutures to aid in hemorrhage 
control and prevent urine leakage.  Effectiveness of the closing method is typically 
evaluated and improved, if necessary, upon removal of the hilar clamp and perfusion of 
the renal remnant.  In this method suture tension is applied based on the experience of 
the medical professional, to a level expected to be approximately equal that required for 
control of bleeding.  Following perfusion, suture tension is increased as necessary to 
control any bleeding which is observed. 
 
 
 
 
 
 
 Figure 1: Trocar Placement (modified lateral camera placement)
      (From ‘Urology 101 RCC by Dr. Brian Lane) 
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Post-Operative Urologic Complications 
Studies of post urologic complications to date have focused on one of two areas.  First, 
emphasis has been given to assessing the viability of a particular method of treatment.  
Those efforts have concentrated on documenting the value of undertaking the more 
rigorous minimally invasive procedures over open ones.  The other frequent focus of 
study is evaluation of one particular product or procedure with respect to another.  The 
literature search has not revealed a quantitative assessment of the means by which 
post-operative urologic complications occur. 
Several studies have analyzed numerous pre-, intra- and post-operative factors to 
establish correlations which will likely lead to improved patient care.26 27  Such research 
has led to the determination that laparoscopic NSS has distinct advantages over radical 
surgeries.28  In addition, studies have associated LPN with an improved mortality.29  
Other studies have evaluated various products such as the holding strength of 
absorbable clips used to terminate sutures30 or the ability of hemostatic materials to 
control blood loss under particular conditions.31 
These studies have contributed to the best application of materials and methods to 
achieve more optimal outcomes for the patients.  However, at the present time, no 
publications address the question of how bleeding and urine leakage, which is 
controlled at the time of closure, becomes uncontrolled at a point 7 to 10 days 
subsequent.  Available statistics only indicated that a urologic complication occurred.  
They do not identify what underlying cause created hemorrhage or urine leak.   
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Concerns with Closure of the Renal Remnant 
The fact that control of bleeding and urine leakage is established and observed prior to 
closing in LPN and reoccurs at a later time implies an intervening event which changed 
conditions substantially.  Numerous factors exist which could generate the occurrence 
of complications.  Investigation of those factors is scant.  It is therefore logical to begin 
with a study of those variables which are known to have changed measurably during the 
procedure and could change further post-operatively. 
A major factor in control of both bleeding and urine leakage is the closing system.  
While some small, peripheral tumors have been removed without the aid of sutures, the 
vast majority of surgeries involve a sutured closing system.  The term ‘closing system’ is 
introduced here to underscore that the suture is not an isolated device which completes 
the function.  Rather, it is one of a number of elements which must perform satisfactorily 
for the purpose to be served. 
Related Research 
Existing documentation on suture tensions and how sutures fail is limited.  
Manufacturers routinely test suture material for tensile strength as part of quality control 
procedures.  Attempts to estimate life under several conditions have also been recorded 
by researchers concerned that absorbable sutures support healing until tissues can 
maintain hemostasis without aid.  In addition, some research has been undertaken to 
evaluate the performance of select products or procedures relative to another.  For 
instance sutures made from natural materials have been compared to synthetic,32 and 
hemostatic agents were contrasted with sutured bolsters.33  However, no quantitative 
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assessment of the suture tension required to achieve hemostasis relative to the tension 
resulting in tissue failure has been identified. 
Suture material is frequently tested in a number of ways.  Initial suture strength is 
commonly reported.  Material manufacturers regularly test their product and maintain 
product consistency.  Tests of suture material are undertaken using the familiar tensile 
testing technique set forth in United States Pharmacopeial (USP) monograph 881,34 
with only a few parameter variations worthy of note.  A “knotted” test which provides a 
stress point in the form of a knot at the center of the specimen, and generally results in 
lower tensile strength, is the most frequently reported specimen configuration.  Another 
often identified variation is the means of securing the ends of the suture for testing.  
Tests are sometimes conducted with the ends of the suture clamped in vise-type 
holders, although this method is only prescribed for sutures of small diameter.  
Intermediate and large diameter material requires the use of specialized equipment 
where the specimen is wrapped around a 19 mm bar and clamped on a 25 mm flat 
surface to reduce the likelihood of a stress point occurring at the edge of the clamp jaw.  
The third variable of concern is the speed at which the force is developed.  This varies 
widely between studies.  However, standard rates are established by the USP. 
As summarized in Appendix 5: Suture Material Strength, several independent 
comparisons of select suture products have been performed.  Some in vitro and animal 
studies have shown that pH and bacterial activity can affect selected products.35 36 37 38  
A few researchers have conducted in vitro and animal tests of sutures to quantify tensile 
strength at selected durations of exposure to environments simulating en vivo use.39 40   
All have used tensile testing at predetermined time intervals to estimate life expectancy.  
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Results from these studies are reported as absolute tensile strength in some cases and 
normalized to initial strength in others.  None of these studies have measured and 
reported the time to failure at the tension necessary to achieve hemostasis in the 
perfused kidney. 
Simon et al. have examined the force required to cause a suture to tear through tissue 
in frequently used configurations (simple, vertical mattress, and horizontal mattress 
formats).41  The forces reported were comparable to those measured in this research.  
However, except in the case of a simple mattress suture, the tension measured was not 
in the direction necessary for wound closure and how the measured force is related to 
the closing force was not addressed.  Nor did that study consider the use of surgical 
clips to terminate simple sutures which is common in laparoscopic procedures. 
Other researchers42 have compared the force required to pull suture anchored with two 
brands of surgical clips through a human kidney.  Those tests reported violation of the 
tissue at 22 Newtons when the suture passed completely through the kidney.  While 
that method was useful in comparison of the two anchors, the results here and in the 
comparison of suture techniques indicate that sutures fail at lower tensions.  Another 
recent study43 measured the force at which sutures terminated with surgical clips could 
be torn from live porcine renal tissue.  In that study, the tension was measured outside 
the animal on the leading suture end which had been extended through the trocar.  
Tensions recorded were higher than reported in this thesis or in the work of Simon et al. 
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Studies have also examined the force required to 
dislodge surgical clips from suture material.44 45  
Those investigations have shown that the larger 
Weck Hem-O-Lok clip (Refer to Figure 2:  
Surgical Clips) is more likely to slip on the suture 
than the Ethicon Lapra-Ty unless provided with 
other support, such as a secondary clip or knot.  
The Weck Hemo-O-Lok backed by a knot (Refer 
to Figure 3: Suture Termination) is used in this project and the current work does not 
investigate this means of termination further. 
Current Investigation of the Forces 
This research quantifies the suture tension applied by a skilled surgeon during the 
closure of a renal defect.  The maximum force that can be applied prior to tissue 
Figure 2:  Surgical Clips 
Figure 3: Suture Termination 
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damage and the effect of 
margin distance on this 
failure point were also 
observed.  In addition, 
strength of absorbable 
sutures over time which have 
been reported previously are tabulated and considered to assess the importance of 
suture selection.  Provided with such information, it may be possible for medical 
professionals to minimize the affected tissue and improve outcomes by reducing the 
margin size to the least amount which will reliably support the suture. 
Initial consideration of the sutured closing system identified the suture, the suture 
termination, and the affiliated tissue which supports the suture as key components in 
the system.  Clearly, the suture will not re-approximate the wound unless it is attached 
to the tissue being closed.  To accomplish this most sutures must be terminated to the 
parenchyma in some manner, either with a knot or surgical clip (Refer to Figure 4:  
Sliding-Clip Renorrhaphy Configuration).  In as much as published methods for MIPN46 
recommend the use of surgical clips as a means to minimize warm ischemia time, and 
that practice is commonly used in local hospitals and major medical centers, a clip-
terminated suture architecture is considered here. 
Critical to evaluating the adequacy of available suture tensile strength and supporting 
tissue forces is knowledge of the force required to re-approximate the renal remnant.  
The tension applied to sutures during the process of closing the surgical site is not 
currently measured in a typical NSS procedure.  No studies were identified that 
Figure 4:  Sliding-Clip Renorrhaphy Configuration 
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documented these measures during closure of a resected kidney.  Without a basic 
knowledge of the force required to close the wound, it is impossible to assess the 
sufficiency of the components of the system.  Hence, this work examines the closing 
force in detail. 
Estimates of the suture strength are readily obtained using currently available 
equipment.47  More difficult is the measurement of in vivo product life expectancy and 
development of associated time-strength relationships.  Conditions approximating those 
in the reconstructed kidney can only be simulated outside of clinical practice.  However, 
multiple previous studies have derived estimates of suture life expectancy using a 
variety of approaches.  The results of identified works in this area which have been 
published since 2002 are summarized in the results section below. 
Finally, the force generated in the suture must be opposed by an equal force in the 
tissue.  Medical professionals attempt to provide sufficient anchoring of the suture 
through selectively choosing the amount of tissue to be enclosed within the suture loop.  
However, placement of the suture is based on experience and not objective data.  The 
ideal amount of tissue required to be enclosed within the suture loop to provide 
sufficient anchoring is currently unknown.  The impact on anchoring ability of changing 
margins to enclose additional tissue is also unknown.  In general, surgeons wish to limit 
the margin’s size to limit the potential for additional tissue damage.  The concern is that 
pressure applied to tissue within the suture loop restricts blood flow and inhibits proper 
renal function.  Consequently, it is desirable to determine the minimal margin that will 
reliably provide the necessary support for the suture. 
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Research Objective 
The initial research considered two forces related to the suture closing system using 
porcine tissue in in vitro tests.  Specifically, applied suture tension and the maximum 
force that can be supported by renal tissue were identified as key factors in the success 
of a re-approximation which warranted testing. 
The tension necessary to re-approximate renal tissue subsequent to tumor removal was 
measured in several trials.  Actual tension imposed by the oncologic urologist was 
determined in multiple sutures used to close representative defects.  To better 
understand the impact of systolic blood pressure, conditions representing both normal 
blood pressure and hypertensive cases were examined.  Apparatus and software 
sufficient to collect the required data were designed and implemented. Revisions were 
made based on initial trials to improve the method of measurement leading to more 
consistent data collection.  Details are presented in the Methods section below. 
Following revisions to the testing method, additional series of data were collected to 
provide more statistical credence to the mean and deviation values previously 
computed.  The principle change to the suture tension experiment after early trials was 
the fabrication of a device which supported the force gauge and facilitated application of 
continuously increasing tension.  The suture tear out test was revised from a design 
which relied on manual application of force, to one in which force was applied through a 
custom designed apparatus and a computer controlled machine that increased tension 
in the suture with a constant velocity motion. 
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Early attempts to measure the ability of the kidney tissue to oppose the suture tension 
produced varied results.  Destructive testing of the closing system was used to 
investigate the suture tension at which the tissue will no longer support the suture.  The 
initial concept was to relate the amount of tissue enclosed within the suture loop, 
referred to as margin, to the tension which could be supported.  However, tests 
revealed that the impact of increasing the margin is not the only factor that determines 
ability to support suture loading and may well be a secondary consideration to other 
variables.  Therefore, an adapted experiment design was executed which sought to 
quantify the range of values that can be expected.  Specifically, the angle of the suture 
entering the capsule and tensioning speed were better controlled and measured. 
However, precise control of the angle of applied force proved difficult in working with 
soft tissue, such as a harvested organ.  It was noted in the experiments that samples 
tend to deform and shift when force is applied to any point.  Furthermore, organs in the 
lab cannot be provided with the uniform support afforded in vivo.  Due to the continuous 
curvature of the renal capsule and variation in placement of each suture, a fixture ideal 
for testing one suture is imperfect for testing others.  Consequently, the later tests were 
conducted on hemispheres of kidneys which had a flat surface to be placed against the 
test fixture.  The angle of the suture relative to the organ surface was then estimated.  
The resulting data was examined for relationships between suture angle and force 
developed, as well as margin size. 
Also, a new, auxiliary experiment was added to measure the bearing strength of porcine 
renal tissue by applying force to a tissue section of known dimension with sutures of 
selected diameters.  In this supplemental test, the suture was observed to determine the 
applied pressure, at which the suture began to sever the tissue. 
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Information related to the expected useful life of suture material commonly used in re-
approximation of the renal remnant was collected from a review of literature reporting 
previous research.  Identification of suture material, initial strength, testing environment, 
ending strength, and time-to-final measurement are tabulated and presented below.  
Multiple studies were identified during a literature review which suggest that some 
absorbable suture materials’ strength remains approximately an order of magnitude 
higher than average suture tensions needed to control bleeding and urine leakage 
during the first 10 days after surgery.  A sampling of those studies is summarized for 
comparison with suture tension measurements obtained in this research. 
Materials 
Tissue samples for each round of testing were obtained from one of two plants 
processing agriculturally raised pork.  The office of the Grand Valley State University 
institutional review board confirmed that tissue acquired from byproducts of normal 
meat production did not require committee review or approval when used in this study. 
Samples were obtained as proximate to the time of testing as possible.  The period 
between harvest and experiment varied from 4 to 80 hours.  Quality was preserved by 
keeping specimens on ice during the storage interval. 
Kidneys used in the first experiments were in a condition typical of pork industry by-
product.  The capsule and most fatty tissue had been removed.  Agricultural inspectors 
had cut into most organs as part of the inspection process.  Those incisions had no 
impact on experiments to assess failure forces and were incorporated into the defect 
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being repaired for tensioning measurements.  Organs obtained for the last two rounds 
of testing were complete with all associated fat, capsule, external vessels and ureter. 
Methods 
Suture Tension 
Suture tension data was obtained using a Wagner FDV-10 digital force gauge (DFG) 
with a 10 pound (0 to 44 Newton) load cell in place which reported force to 0.1 N 
resolution.  Calibration was checked by hanging laboratory masses from the force 
gauge and verifying the display value.  Measurements were obtained by having the 
surgeon place sutures in a manner similar to those used in closing partial 
nephrectomies on human patients.  The surgeon applied tension to the sutures based 
on visual and tactile queues while applied tension was recorded by the force gauge.  
Tension was achieved by placing the tip of the tensioning jig against the leading surgical 
clip and pulling on the end of the 
suture until the appropriate 
tension was achieved (Figure 5:  
Tensioning Configuration).  
Original measurements were 
attempted with the assembly 
handheld (Refer to Figure 6:  
Original Handheld Equipment and 
Figure 7:  Handheld Tension 
Measurement).  Addition of a 
stand to support the DFG / jig assembly and a worm gear apparatus to apply increasing 
Figure 5:  Tensioning Configuration 
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force, resulted in a sufficient level of control 
to acquire useable tension data (Refer to 
Figure 8:  Stabilized Tension Measurement). 
 
 
 
Figure 6:  Original Handheld Equipment 
Figure 7:  Handheld Tension Measurement 
Figure 8:  Stabilized Tension Measurement 
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To collect tension measurements, an interface cable was 
constructed to connect the Wagner force gauge to a Future 
Technology Devices International Ltd. USB/Serial converter 
(Refer to Figure 10: FTDI USB to Serial Converter) connection 
to a Hewlett-Packard Pavilion dv6 laptop computer running 
Microsoft Windows 7 (64 bit) with all released updates installed 
and using the FTDI supplied converter driver (version 
2.8.24.0). 
 
Software was written using 
the 2012a version of 
MatLab (The MathWorks, 
Inc.) to record and post 
process tension data 
(Refer to Figure 9:  Data 
Collection Process).  The 
program included a graphical 
user interface (Refer to Figure 
11:  Graphical User Interface) 
which provided START/STOP 
control with feedback and 
real-time graphing of force 
measurements being 
recorded.  Use of post-
Figure 10: FTDI USB 
to Serial Converter 
Figure 11:  Graphical User Interface 
Figure 9:  Data Collection Process 
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processing eliminated the need for multiple calculations and writing data to the hard 
drive during the experiment.  Postponing those operations until after data collection 
stopped prevented delays in data collection caused by time consuming routines.  This 
allowed some image (time lapse) collection to be performed simultaneously on the 
computer used to collect force measurements without detrimental effect on sample 
collection (Refer to Appendix 6:  Post-Experiment Processing of Data Files). 
The ‘pause’ command was used with a 0.1 second delay parameter in the data 
acquisition software to limit the number of samples collected.  The actual sampling 
interval varied slightly, presumably due to process burden from other applications (video 
capture) being run.  Examination of randomly selected trials from four different days 
indicated that the mean interval was slightly greater than 0.21 seconds with a standard 
deviation of less than 2.5 x 10-7 (Refer to Figure 12:  Examination of Sampling Interval).  
This was considered to be adequately fast to capture the changes in tension which 
occurred slowly.  That 
determination was made after 
noting that one or more data 
points were recorded during the 
period of increasing tension in 
failure experiments. 
Tissue Strength 
 The original goal was to 
investigate the relationship of suture margins and depths to the amount of suture 
tension required to cause failure of the tissue.  Tests were conducted using the Wagner 
Figure 12:  Examination of Sampling Interval 
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DFG and the same computer arrangement as used for tensioning measurements.  For 
the first trials, the DFG was removed from the jig used for tension tests, attached to 
each suture, and pulled by hand until the suture was torn from the parenchyma.  The 
tissue samples were restrained by placement behind an acrylic panel with a 1.5 cm slot 
for the suture tail (Refer to Figure 13:  Acrylic Sample Restraint).  Observations made 
during these tests led to trials using other procedures in an effort to control the force 
resulting from acceleration and the angle of applied force. 
Additional trials were conducted with the 
DFG mounted on the same jig and support 
stand used for collection of tension 
measurements.  For these tests, the 
arrangement of the sample and apparatus 
was similar to tensioning tests, with the jig 
placed as near perpendicular to the organ 
surface at the leading clip location as 
possible.  Failure tension data was obtained by continuing to increase the force on the 
suture until the tissue gave way and the tension in the suture decreased rapidly (Refer 
to Figure 11:  Graphical User Interface for an example). 
To further control the effect of acceleration on the recorded force and provide easier 
estimation of the angle of applied force, later experiments utilized mechanical 
application of force on hemispheres of tissue.  Consequently, the suture configuration 
tested more resembled half of a closing suture, i.e., pulling one anchor toward the 
defect. 
Figure 13:  Acrylic Sample Restraint 
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Implementation of this method employed a MTS Mini-Bionix test station, including 
system control software running on a desktop personal computer operating Microsoft 
Windows XP.  The Mini-Bionix force transducer was removed from the test frame and a 
test jig was fabricated and attached to the frame in its place (Refer to Figure 14: 
Revised Failure Test Setup Plan and Figure 16: Revised Failure Test Setup).  MTS 
software was used for the test station ram speed control only.  To measure the force 
applied, the clamping jaw was removed from the MTS, an adapter which allowed a free 
moving connection was created (Refer to Figure 15: DFG / MTS Connection), and the 
Wagner DFG was attached to the Mini-Bionix ram.  Travel speed of the ram was 
adjusted to a constant 1 cm per second to allow the influence of acceleration during the 
period of tissue failure to be ignored. 
Figure 14: Revised Failure Test Setup Plan 
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The tension force was translated from vertical to 
horizontal using a small Nylon pulley with metal 
ball-bearings and raceway.  To evaluate friction in 
the pulley, four revolutions of a suture were 
wrapped around the pulley and it was accelerated 
from stationary using the DFG.  No appreciable 
friction was detected. 
Samples were retained using the same acrylic 
sheet used in early tests.  Blocks were placed 
under the specimen as necessary to achieve the 
desire alignment with the pulley axis.  Stabilization 
Figure 16: Revised Failure Test Setup 
Figure 15: DFG / MTS Connection 
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of samples was attempted using plastic bags containing pieces of ice.  Ultimately, it was 
found that the most reliable support was achieved using cushions formed from damp, 
paper towelettes (Refer to Figure 17:  Sample Support).  The ability of the paper to 
absorb moisture reduced the tendency of each kidney segment to shift during the 
application of force.  Although contact with the paper was not in the area of the sutures 
being tested, the impact of using an absorbent material on the tension at failure is 
unknown. 
The failure test configuration using the Wagner gauge with the MTS Mini-Bionix test 
station enabled force measurements to be recorded with the same software used in 
tensioning experiments.  Additional documentation was provided by recording high 
definition digital video of the failure using a conventional web camera and a third 
personal computer.  This allowed careful review of the failure as it proceeded, as well as 
providing a means for confirming the test procedure used. 
The effect of suture angle on 
the tissue’s ability to support 
tension was assessed by 
visually estimating (Refer to 
Figure 14: Revised Failure Test 
Setup Plan) and recording the 
angle of the renal capsule at the 
point of the suture anchor 
relative to the test fixture.  Angle 
of the anchoring surface was 
Figure 17:  Sample Support 
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determined by estimating the tangent line and measuring with a protractor.  
Tissue Strength – Auxiliary Experiment 
To further define the renal 
tissue’s ability to support 
applied force, an auxiliary 
experiment was designed in 
which a segment of suture 
material was held taut at a 
predetermined tension and 
pressed against a flat surface 
of porcine kidney tissue until 
the suture material cut 
through the parenchyma 
(Refer to Figure 18:  Cross-Section Sample Test Arrangement).  The tissue samples 
were segments of organs which were cut to specific dimensions.  The concept was to 
test material surfaces with known dimensions, thereby allowing calculation of 
normalized (per unit area) bearing forces at failure.  Surface area was calculated as the 
diameter of the suture multiplied by the width of the tissue sample and neglected the 
effect of the curvature of the suture surface.  Suture diameters were assumed to be the 
manufacturer specified diameter or the USP standard if no manufacturer information 
was available. 
A device to hold 1 and 2 cm square strips of parenchyma was constructed (Refer to 
Figure 19: Aux Test Setup).  That assembly was secured to the MTS test frame bed.  
Figure 18:  Cross-Section Sample Test Arrangement 
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Suture was stretched between 
two acrylic pieces suspended 
from the Wagner force gauge 
attached to the MTS Mini-
Bionix ram.  Ram control and 
data acquisition were achieved 
in the same manner used for 
failure tests.  The ram was fully 
extended to allow the suture to 
rest in a groove below the 
tissue slot.  Specimens were placed under the acrylic sheet between two blocks which 
were spaced at the dimension being tested.  This resulted in the segment being 
supported on all sides with a 1 cm gap where the suture could be drawn through (Refer 
to Figure 20:  Auxiliary Test on Sample). 
Suture Strength 
To assess the strength of suture material, initially a search of PubMed was conducted 
for English language articles with the terms ‘suture’ and ‘mechanical’, as well as ‘break’ 
or ‘failure’, but not ‘technique’ in any of the fields (Refer to Appendix 4:  PubMed Search 
Criteria & Results).  The resulting large number (385) citations were scanned and the 
search narrowed by using the search engine feature which selects publications related 
to one of the studies48 which contained useful information on suture strength.  The 
identified documents were reviewed and placed in the spreadsheet shown in Appendix 
5:  Suture Material Strength.  Eleven articles written in English and published in the last 
Figure 19: Aux Test Setup 
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ten years (since 2002), which provided useful information about suture useful life, were 
able to be identified and obtained.  Each was reviewed for suture material life 
expectancy information and information about test conditions.   
Results & Discussion 
Suture Tension 
Thirty-nine sutures were placed in renal specimens during trials on four different days.  
Not all sutures provided usable data at each perfusion state due to tearing of the tissue.  
In addition, early tests were not run at hyper-perfusion pressure.  One suture was 
measured twice with slightly different results.  Both values are included in the data set.  
Figure 20:  Auxiliary Test on Sample 
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Sutures which were missing data points for any of the three levels of perfusion were 
included in calculating statistics. 
Tension values were determined during post-experiment processing using a MatLab 
algorithm which determined the highest tension recorded in four consecutive sample 
intervals with a tolerance of ± 0.1 Newton variation.  This method provided an objective 
means of screening variation resulting from the measurement process.  Values obtained 
with this procedure were similar to those noted by the research team during the 
experiments. 
Figure 21:  Scatter Plot of Suture Tension shows the suture tensions recorded with a 
supported tensioning device.  Tensions recorded with the handheld gauge are not 
included.  Values corresponding to ischemic, perfused to 120 mmHg (64.2 inches H2O) 
pressure and perfused to a hypertensive pressure greater than 220 mmHg (118 inches 
H2O) for each suture are shown together along the horizontal axis.  It can be seen that 
in nearly all cases the hypertensive (red) and perfused (blue) values are above the 
ischemic (green).  This is confirmed by comparison of the means and standard 
deviations as calculated using the ‘average’ and ‘stdev.s’ functions in Microsoft Excel 
2010.  The values obtained are shown in  Table 1:  Suture Tension. 
An analysis of variance on suture tensions using the software revealed significant effect 
related to tension (p < 0.0001).  Tukey HSD post hoc analysis showed that the tensions 
in a perfused and hypertensive kidney are both significantly greater than in an ischemic 
kidney (both p < 0.0001), which was similar to comparisons using Students T test (p < 
0.0004 and p < 0.0001, respectively).  However, no significant difference was detected 
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at the 95% confidence level between the tension in a normally perfused specimen and 
one perfused to more than 200 mmHg (p = 0.0584). 
 
 
  Table 1:  Suture Tension 
Ischemic Perfused Hyper-perfused
n 37 39 32
Mean tension (N) ± SD 2.78 ± 0.74 3.24 ± 0.71* 3.42 ± 0.70*
95% C.I. of Tension Mean 2.54, 3.02 3.02, 3.46 3.18, 3.66
Mean absolute increase ± SD -- 0.47± 0.66** 0.65 ± 0.75**
95% C.I. of Increase Mean 0.24, 0.70 0.39, 0.91
Mean % increase ± SD -- 21% ± 28%** 29% ± 31%**
*p<0.001 vs. ischemic (paired t-test); **p<0.001 vs. null (paired t-test). 
N, newtons; n, sample size; SD, standard deviation
Figure 21:  Scatter Plot of Suture Tension 
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Tissue Strength 
The force required to destructively remove (tear) sutures from renal tissue was 
measured using four different approaches.  In the first two trials, a renal defect was 
closed using sutures having margins of 0.5, 1.0 and 1.5 cm.  As shown in Figure 13:  
Acrylic Sample Restraint, the sample was then placed behind the slotted acrylic sheet 
and force was applied to the leading end of the suture with the handheld DFG until 
failure occurred.  Figure 22: All Handheld Failure Test Data shows the measurements 
obtained in this manner.  Although the linear fit line indicates a positive correlation 
between margin and force required to cause failure, Students’ T Test comparison of 1.0 
cm versus 0.5 cm and 1.5 cm versus 1.0 cm revealed no significant difference. (p = 
Figure 22: All Handheld Failure Test Data 
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0.1713 and p = 0.1066, respectively)  However, there was a difference between 
sustainable force when considering 1.5 cm margins to 0.5 cm margins (p = 0.0175). 
Examination of the trial sessions individually revealed that significant differences 
occurred in tests on sutures at 1.0 cm and 1.5 cm between the two sessions (p = 0.0234 
and p = 0.0036, respectively) even though the procedure did not differ.  No significant 
difference was detected between the two occasions for sutures installed at 0.5 cm (p = 
0.8166).  The differences between the two test sessions can be seen in Figure 23: 
Handheld Failure Test by Session.  Note that the coefficient of determination (R2) for the 
Session 1 linear fit line is particularly low indicating the inadequacy of that data as a 
predictor.  On the other hand, data from only Session 2 registered a better coefficient of 
Figure 23: Handheld Failure Test by Session 
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determination and showed a more positive relationship between margin and tension at 
failure.  Comparison of 1.0 cm and 1.5 cm margins to 0.5 cm margins, as well as 1.5 cm 
to 1.0 cm, revealed significant differences  (p = 0.0344, p = 0.0013 and p = 0.0271, 
respectively) for that trial.  Furthermore, the slope of the fit line for Session 2 was similar 
to the one found in later tests (Refer to Figure 24: Failure of Model Suture Tested with 
Stabilized System). 
The second test method employed for measuring failure force data was the same 
supported test jig arrangement used for tensioning tests.  The data shown in Figure 24: 
Failure of Model Suture Tested with Stabilized System was obtained during trials on two 
Figure 24: Failure of Model Suture Tested with Stabilized System 
  44 
separate days by tensioning the sutures with that apparatus until failure occurred.  In 
those tests, sutures were placed by the surgeon and measured to the nearest tenth of a 
centimeter prior to testing.  The result was that the margin assumed additional values. 
Comparison of the two trial sessions for this method resulted in a relationship between 
margin and failure force on Session 4 which was inconsistent with Session 2 and 
Session 3.  However, the value of that fit line slope was discounted due to the fact that 
only five data points were obtained during that trial and one (margin = 1.0 cm, force = 
16.3 N) was considered to be a clear outlier from the other two points at 1.0 cm (mean = 
2.85 N).  This resulted in the fit line for data from Session 4 having a R2 = 0.06 
compared to 0.33 for the Session 3 data alone and 0.25 for the combined data. 
While the Session 4 data points are not considered separately, all five are included with 
the data shown in Figure 24: Failure of Model Suture Tested with Stabilized System.  If 
those points were removed, the fit line slope changes slightly from 13.7 N/cm to 12.7 
N/cm. 
In the third experimental configuration, the arrangement was similar to that used in the 
previous tests.  However, in the third protocol the sample was bisected along the line of 
the defect and tension was applied perpendicular to the exposed parenchyma (Refer to 
Figure 25:  Failure Test on Organ Hemisphere Using Tension Jig).  As shown in Figure 
26: Failure of Half Suture With Tension Device, only six sutures were tested in this 
manner and the coefficient of determination for the fit line was extremely low. (R2 = 
0.04)  Removal of the data point at 1 cm / 0.1 N reduced the coefficient of determination 
even further. 
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The final data sets 
for failure force 
were obtained using 
the MTS test station 
to apply force.  For 
those experiments 
samples were 
bisected as in the 
previous group.  
Also, some specimens included the connective tissue membrane, while others were 
bare organs. 
 
Figure 25:  Failure Test on Organ Hemisphere Using Tension Jig 
Figure 26: Failure of Half Suture With Tension Device 
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Figure 27: Constant Velocity Failure Force versus Margin - All Samples shows the 
forces measured relative to the margin for each of the angles tested between 30° and 
315° (applied upward from the surface at 45° as shown in Figure 28:  Angles of Applied 
Tension).  Results from tests at angles between 55° and 80° are omitted from this graph 
because of the irrelevance of margin at such high angles.  Measurements at angles 
approaching 90° (normal to the organ surface) equate to pulling the suture through the 
sample and the thickness of the sample becomes a more applicable dimension than the 
margin. 
Figure 27: Constant Velocity Failure Force versus Margin - All Samples 
  47 
The tension at failure for samples without connective membrane tissue is shown in 
Figure 29: Constant Velocity Tests on Samples without Connective Membrane.  The 
Pearson statistic, r, which is the square root of the coefficient of determination, was 
examined for those samples.  Critical values were obtained from tables.  Despite 
indication of a positive relationship for both groups on the graph, the Pearson test 
(critical values equal 0.997 for n = 3 and 0.576 for n = 12) revealed no significant 
relationship in either group at the 95% confidence level. 
 
Figure 29: Constant Velocity Tests on Samples without Connective 
Membrane 
Figure 28:  Angles of Applied Tension 
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Consideration of measurements made on samples with the connective membrane 
(Figure 30: Constant Velocity Tests on Samples with Connective Membrane) appeared 
to have a negative relationship with margin at an upward angle of 45° (-45° or 315°).  
However, application of the Pearson test determined that the relationship between 
margin and tension at failure was not significant (critical value equal to 0.444 for n = 20) 
for tests at 315°.  With force applied at 0° (parallel to the organ surface) a positive 
relationship with slope similar to that recorded in manual, bisected samples (Figure 26: 
Failure of Half Suture With Tension Device) was seen.  Analysis determined a 
significant (99% critical value equal to 0.798 for n = 9) Pearson r – value of 0.81 for the 
relationship between force applied parallel to the capsule surface necessary to cause 
failure and margin. 
 
 
 
Figure 30: Constant Velocity Tests on Samples with Connective Membrane 
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When analyzing the relationship between angle of applied force and the tension at 
which failure occurs, it was found that angles between 0° and 90° have a strong positive 
relationship with the force in specimens without connective membrane tissue present 
(Refer to Figure 31:  Failure Force at Low Angles in Constant Velocity Tests).   The 
linear fit line was determined to have a Pearson statistic of 0.86 which is significant at 
the 95% level. (Critical value equal to 0.456 for n = 19)  Although no correlation was 
observed for all samples with the membrane intact, consideration of data taken at low 
angles (Refer to Figure 31:  Failure Force at Low Angles in Constant Velocity Tests) 
only yields an interesting result.  The fit line for those trials has a similar slope and 
crosses the y axis (zero crossing) at nearly identical tension value as was obtained 
Figure 31:  Failure Force at Low Angles in Constant Velocity Tests 
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when data from samples without the connective membrane intact were examined (Refer 
to Figure 32:  Relationship of Angle to Failure Tension in Samples with Membrane 
Intact).  In both cases, the linear fitted relationship is between 0.1 and 0.2 Newton per 
degree over the range of 0° to 90°.  Zero crossings are slightly greater than 4 Newtons 
in both instances.  However, caution is warranted in use of the data from samples with 
their membrane intact inasmuch as only two points greater than 0° were used in the 
analysis. 
Tissue Strength – Auxiliary Experiment 
An apparatus was prepared to test samples 1 and 2 cm square by approximately 7 cm 
long.  However, at the time of testing, it was determined that adequate specimens with 
Figure 32:  Relationship of Angle to Failure Tension in Samples with Membrane Intact 
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dimensions required for the 2 cm test could not be consistently cut from the organs 
without involvement of the collecting system.  Consequently, tests were performed with 
1 cm square samples only. 
During testing, some movement of the tissue was noted.  Samples would tend to bend 
upward between the acrylic panel sections retaining the parenchyma.  However, the 
contact surface area and thickness of the sample opposing the suture were not seen to 
change.  Therefore, the data obtained was analyzed. 
Three trials were performed using #3-0 Vicryl™.  The diameter was assumed to be 
0.018 mm, based on manufacture literature.  Area of the applied force was assumed to 
be the suture diameter times the sample width and was calculated to be 0.18 mm2.  As 
seen in Figure 33:  Applied Force Required to Penetrate 1cm Segment, the mean 
Figure 33:  Applied Force Required to Penetrate 1cm Segment 
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applied force at the time of tissue failure was 5.5 ± 0.5 Newtons.   The mean unit 
pressure was calculated to be 30.6 ± 2.9 MPa. 
Six tissue samples were tested using #1Vicryl™.  Najibi et al.49 found the diameter of #1 
Vicryl™ to be 0.51 mm through direct measurement.  The experimental surface area 
calculated using that dimension was 5.1 mm2.  The mean maximum force recorded 
during testing of #1 size suture was 6.2 ± 1.3 N and the resulting pressure was 
calculated to be 1.2 ± 0.26 MPa. 
Although the chart in Figure 33 appears to show a slight increase in bearable force with 
larger surface area, analysis using the Students T Test found that no significant 
difference existed for the force borne using the two different suture diameters. (p = 
0.293)  However, using the same statistical method to compare the pressure (force per 
unit area) revealed that there was a significant difference (p = 0.003) in the applied 
pressures calculated using the method for estimating surface area described above. 
Suture Strength 
Reported forces were converted to Newtons and tabulated.  When failure data was 
provided in mega Pascals (MPa), conversion to Newtons was based on the suture 
diameter provided or on manufacturer information.  When data was provided in graphs, 
rather than tables, the graphs were enlarged and values estimated by inspection.  
Values obtained in this manner compared well in the few instances where actual values 
were provided in the article text. 
Appendix 5: Suture Material Strength lists the suture life data obtained, as well as the 
year of publication and principal author’s name. 
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Conclusions 
Re-approximation of soft tissue is a delicate task requiring the precise talents of skilled 
surgeons.  Kidneys are among the organs requiring special techniques for the closure of 
defects.  Despite advances in ablation and adhesive hemostatic agents, sutured closure 
remains a common practice in renal surgery. 
Surgeons typically apply closing force by experience and observing changes in the 
character of the tissue.  In this research, the tension in sutures used to close sites 
similar to those of tumor removal was found to generally be in the range of a few 
Newtons.  In addition, it was observed that the tension required to control leakage and 
bleeding in a perfused organ is greater than that required simply to achieve 
approximation.  In no instance were tensions over 5 Newtons recorded.  However, more 
than 2 Newtons of tension was always required to achieve hemostasis in the perfused 
kidney.  These conclusions are based on a specific combination of suture diameter, 
sliding clamp and backstop knot.  Different tensions may be required under different 
conditions, particularly if a clip is employed that has a different surface area in contact 
with the kidney surface.  The particular form of the closure system chosen for this 
research is the one most commonly in use for current LPN procedures. 
Testing of the installed suture to determine the amount of additional tension beyond that 
necessary for adequate hemostasis which would cause failure of the tissue to provide 
the force required, is difficult; due in large part to the nature of soft tissue and its 
tendency to deform under slight pressure.  A variety of tests performed on both full and 
half sutures reveals that arrangements with margins greater than 0.5 cm can provide 
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two, three or more times the support necessary.  Both margin and angle to the capsule 
surface were shown to affect the sutures’ ability to deliver the needed forces. 
Indications exist that extremely small margins, particularly less than 0.5 cm, will not be 
suitable for many tensions and that care should be used in use of margins less than 
approximately 1 cm. 
The ability of the tissue and suture anchor to support applied tension can be improved 
significantly by increasing the angle of the applied force relative to the organ surface.  
For angles between 0° and 90° the tension necessary to cause failure increases rapidly 
with the angle.  However, the force usually needed for closure is generally applied at an 
angle near zero.  Consequently, medical professionals need to be conscious of the 
angle of the suture with respect to the organ surface when tension is applied. 
While it might be expected that use of a suture with greater surface area would 
distribute the force over a larger amount of tissue and increase the tissues’ ability to 
support the suture, in experiments on only nine samples in the auxiliary test no trend 
was evident.  Based on the surface area calculation described above, and the 
measured forces at the time of penetration, the pressure per unit area sustainable by 
the tissue is not the same.  Therefore, it is likely that the model used to estimate the 
distribution of force is incorrect, samples were not representative of the population, or 
physical properties of kidney tissue behave in an unusual manner. 
Evaluation of peer reviewed literature regarding the longevity of suture materials in a 
number of environmental conditions found that many suture materials with initial tensile 
strengths exceeding common renal suture tensions are available.  Some have been 
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shown to maintain their qualities for seven to ten days which is thought to be 
appropriate for healing following renal closure.  However, environmental conditions, 
particularly bacteria and pH, have been shown to adversely affect suture life 
expectancy, especially in natural fibers (silk and catgut) and uncoated polyester.  
Furthermore, some suture materials, particularly small diameter (5-0), have initial tensile 
strengths which are close to tensions seen in simulated closures of perfused and hyper-
perfused organs.  Consequently, it is important that the medical professional select 
suture material for renal closure carefully. 
Topics for Additional Research 
This research exposed a number of opportunities for future work in the subject area.  
First, while tensions developed in sutures were measured on a number of occasions 
with enough consistency to provide reasonable insight into the values necessary for 
hemostasis at closure, less uniformity was achieved in quantifying the tension at failure.  
A number of techniques were applied in an attempt to find a method representative of 
tensions that would cause sutures placed by a surgeon to fail.  However, this subject 
warrants further consideration. 
Among the topics to be examined with regard to suture failure is a better identification 
and quantification of the factors which affect the tension developed before failure.  This 
research indicates that both margin size and angle play a role.  However, data 
accounting for additional quantifiable factors is required to determine which are 
independent and significant.  Among the factors which need to be assessed besides 
margin size and angle are time between harvest and test, temperature, suture depth, 
inclusion of fibrous membrane tissue and use of pledgets. 
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The auxiliary experiment performed to provide additional information about failure of the 
tissue to support the suture tension is limited both by the small sample size and 
questions raised regarding distribution of force on the surface.  A larger sample may 
reveal that a significant difference in tension supported by different diameter and 
materials of suture.  Differences in sustained unit pressure (force per unit area) may 
also play a role. 
Finally, if additional data confirms that the angle of suture tension relative to the organ 
surface is an important factor as the initial data indicates, efforts should be made to 
improve the method of closure.  In many cases, the forces required for defect closure 
are in a direction parallel with the organ surface.  If it can be shown conclusively that 
forces applied in a near normal direction reach greater magnitudes before failure, a 
method to translate closing forces to a normal direction might be useful in surgical 
practice.    
  
  57 
 
 
 
 
 
 
 
 
Appendices 
  
  58 
Appendix 1: Peak Suture Tension Data 
SAMPLE ID 
IS
C
H
E
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IC
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D
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 P
E
R
F
U
S
E
D
 
Jul29_1 2.6 3.6  
Jul29_3 3.0 3.9  
Jul29_4 2.6 3.5  
Jul29_6 2.5 3.5  
Jul29_7 2.8 3.2  
Aug16_1A 3.8 4.7 5.0 
Aug16_1B 4.2 4.3 4.7 
Aug16_1C 4.0 4.6 5.0 
Aug16_2A 3.3 3.6 2.6 
Aug16_2B 2.4 2.5 3.2 
Aug16_2Bb 4.1   
Aug16_2C 2.1 2.3 3.4 
Aug16_2D 2.5 2.6 3.0 
Aug16_2E 3.0 3.1 3.5 
Aug16_2F 2.8 3.2 3.5 
Aug16_2G 2.3 2.7 3.0 
Aug29_1A 1.9 2.3 3.2 
Aug29_1B 2.0 4.2 3.2 
Aug29_1C 2.4 2.8 2.9 
Aug29_1D 3.6 2.5 2.7 
Aug29_1E 2.1 3.2 3.1 
Aug29_1Eb  2.2  
Aug29_1F 2.2 2.8 3.3 
Aug29_1G 1.8 2.5 3.4 
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Aug29_1H 2.1 2.7 3.5 
Aug29_1I  3.2 3.4 
Aug29_2A 1.5 2.0 2.2 
Aug29_2B 2.8 2.8 3.3 
Aug29_2C 2.6 3.1 2.5 
Aug29_2D 3.4 3.3 3.0 
Aug29_2E 1.7 2.2 2.8 
Dec14_1A 4.4 4.0 4.5 
Dec14_1B 2.3 3.5 3.7 
Dec14_2A 3.0 3.2 3.3 
Dec14_2B 3.5 3.4 3.6 
Dec14_3A 2.5 4.3 3.5 
Dec14_3B 2.6 4.5 4.9 
Dec14_4A 3.7 3.7 2.6 
Dec14_4B No peak 
found 
3.3 3.7 
Dec14_5B 2.8 3.4 3.5 
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Appendix 2: Suture Failure Data 
Handheld 
TEST  ID M
A
R
G
IN
 
M
E
M
B
R
A
N
E
 
M
E
T
H
O
D
 
1
 
C
O
N
S
E
C
U
T
IV
E
 
P
T
S
 
Jul29___11_25_45_Tr_O_0-5_Nc_1 0.5 None 1 11.4 
Jul29___11_39_36_Tr_O_0-5_Nc_1 0.5 None 1 7.5 
Jul29___11_4_43_Tr_O_0-5_Nc_1 0.5 None 1 5.1 
Jul29___12_14_10_Tr_O_0-5_Nc_1 0.5 None 1 5.7 
Jul29___12_17_52_Tr_O_0-5_Nc_1 0.5 None 1 4.8 
Jul29___12_21_20_Tr_O_0-5_Nc_1 0.5 None 1 2.0 
Jul29___12_26_6_Tr_O_0-5_Nc_1 0.5 None 1 4.7 
Jul29___11_31_43_Tr_O_1-0_Nc_1 1 None 1 16.8 
Jul29___11_42_22_Tr_O_1-0_Nc_1 1 None 1 14.3 
Jul29___11_7_7_Tr_O_1-0_Nc_1 1 None 1 7.2 
Jul29___12_12_26_Tr_O_1-0_Nc_1 1 None 1 14.8 
Jul29___12_19_23_Tr_O_1-0_Nc_1 1 None 1 9.0 
Jul29___12_23_47_Tr_O_1-0_Nc_1 1 None 1 5.9 
Jul29___11_10_42_Tr_O_1-5_Nc_1 1.5 None 1 13.2 
Jul29___11_20_3_Tr_O_1-5_Nc_1 1.5 None 1 23.2 
Jul29___11_45_10_Tr_O_1-5_Nc_1 1.5 None 1 22.3 
Jul29___11_48_24_Tr_O_1-5_Nc_1 1.5 None 1 20.4 
Jul29___11_51_34_Tr_O_1-5_Nc_1 1.5 None 1 14.4 
Jul20___15_40_25_Tr_O_1A_0-5_Nc_1 0.5 None 1 4.7 
Jul20___15_53_54_Tr_O_1E_0-5_Nc_1 0.5 None 1 4.3 
Jul20___16_6_2_Tr_O_1G_0-5_Nc_1 0.5 None 1 6.8 
Jul20___18_54_27_Tr_O_2B_0-5_Nc_1 0.5 None 1 13.1 
Jul20___18_54_58_Tr_O_2C_0-5_Nc_1 0.5 None 1 1.6 
Jul20___18_58_54_Tr_O_2E_0-5_Nc_1 0.5 None 1 7.6 
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Jul20___15_46_57_Tr_O_1B_1-0_Nc_1 1 None 1 3.2 
Jul20___16_3_25_Tr_O_1F_1-0_Nc_1 1 None 1 8.4 
Jul20___16_8_53_Tr_O_1H_1-0_Nc_1 1 None 1 7.9 
Jul20___18_51_13_Tr_O_2A_1-0_Nc_1 1 None 1 5.5 
Jul20___18_57_54_Tr_O_2D_1-0_Nc_1 1 None 1 4.1 
Jul20___19_0_16_Tr_O_2F_1-0_Nc_1 1 None 1 3.5 
Jul20___15_49_52_Tr_O_1C_1-5_Nc_1 1.5 None 1 4.7 
Jul20___15_52_5_Tr_O_1D_1-5_Nc_1 1.5 None 1 2.3 
Jul20___16_12_41_Tr_O_1I_1-5_Nc_1 1.5 None 1 9.8 
Jul20___16_16_58_Tr_O_1J_1-5_Nc_1 1.5 None 1 13.1 
Jul20___17_56_30_Tr_O_1K_1-5_Nc_1 1.5 None 1 6.4 
Jul20___19_1_59_Tr_O_2Q 
Not 
Specified None Unknown 1.3 
Jul20___19_4_4_Tr_O_2R 
Not 
Specified None Unknown 1.1 
Jul29___11_11_35_Failed_Tr_O_Nc_1 
Not 
Specified None 1 25.3 
Jul29___12_29_6_Tr_O_Nc_0_Weck-
Pledget 
Not 
Specified None 0 3.6 
Jul29___12_31_17_Tr_O_Nc_0_Weck-
Pledget 
Not 
Specified None 0 14.6 
Jul29___12_34_42_Tr_O_Nc_0_Weck-
Pledget 
Not 
Specified None 0 16.8 
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Stabilized 
TEST  ID M
A
R
G
IN
 
M
E
M
B
R
A
N
E
 
M
E
T
H
O
D
 
4
 C
O
N
S
E
C
U
T
IV
E
 
P
T
S
 
Aug16___15_13_17_Tr_O_B Not 
Specified 
None 1 5.5 
Aug16___15_14_35_Tr_O_A Not 
Specified 
None 1 5.8 
Aug16___15_7_0_Tr_O_C Not 
Specified 
None 1 27.0 
Aug16___17_10_59_Tr_O_A_1-5_Nc_1 1.5 None 1 14.4 
Aug16___17_13_7_Tr_O_B_1-4_Nc_1 1.4 None 1 18.8 
Aug16___17_15_0_Tr_O_C_1-6_Nc_1 1.6 None 1 23.9 
Aug16___17_17_27_Tr_O_G_1-0_Nc_1 1 None 1 6.0 
Aug16___17_19_35_Tr_O_F_0-8_Nc_1 0.8 None 1 10.9 
Aug16___17_22_7_Tr_O_E_1-5_Nc_1 1.5 None 1 6.2 
Aug16___17_23_10_Tr_O_D_1-0_Nc_1 1 None 1 6.8 
Aug29___12_18_49_Tr_O_B_1-0_Nc_1 1 None 1 16.3 
Aug29___12_29_15_Tr_O_C_1-0_Nc_1 1 None 1 5 
Aug29___12_35_41_Tr_O_D_1-2_Nc_1 1.2 None 1 2.1 
Aug29___12_38_13_Tr_O_E_1-2_Nc_1 1.2 None 1 5.5 
Aug29___12_56_3_Tr_O_B_Back_1-0_Nc_1 1 None 1 0.7 
Aug29___13_1_53_Tr_O_C_Front_Nc_1 Not 
Specified 
None 2 3.1 
Aug29___13_29_51_Tr_O_C_1-4_Nc_2 1.4 None 2 8.9 
Aug29___13_35_55_Tr_O_E_1-0_Nc_2 1 None 2 7.5 
Aug29___13_39_25_Tr_O_E_1-0_Nc_2 1 None 2 3.6 
Aug29___13_42_25_Tr_O_F_1-0_Nc_2 1 None 2 6.4 
Aug29___13_50_13_Tr_O_G_1-0_Nc_2 1 None 2 0.1 
Aug29___13_53_58_Tr_O_H_1-4_Nc_2 1.4 None 2 2.6 
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Powered 
TEST  ID 
M
A
R
G
IN
 
M
E
M
B
R
A
N
E
 
A
N
G
L
E
 
1
 C
O
N
S
E
C
U
T
IV
E
 P
T
S
 
Nov29___17_17_55_Tr_O_2E_0-8_Cp_0 0.8 Yes 0 2.4 
Nov29___17_23_11_Tr_O_2F_0-5_Cp_0 0.5 Yes 0 2.0 
Nov29___17_9_19_Tr_O_2D_1-4_Cp_0 1.4 Yes 0 7.0 
Nov29___18_21_36_Tr_O_3A_1-3_Cp_0 1.3 Yes 0 8.2 
Nov29___18_24_30_Tr_O_3B_1-3_Cp_0 1.3 Yes 0 6.8 
Nov29___18_27_28_Tr_O_3C_1-4_Cp_0 1.4 Yes 0 3.4 
Nov29___18_52_03__Tr_O_3G_0-5_Cp_0 0.5 Yes 0 2.4 
Nov29___18_54_25_Tr_O_3H_0-6_Cp_0 0.6 Yes 0 2.3 
Nov29___18_58_56_Tr_O_3I_0-7_Cp_0 0.7 Yes 0 1.7 
Nov29___15_51_50_Tr_O_1C_x_Cp_65_COL_Not
e 
x Yes 65 18.2 
Nov29___15_37_42_Tr_O_1A_x_Cp_70_Note x Yes 70 5.5 
Dec14___18_32_23_Tr_O_A_0-9_Cp_315 0.9 Yes 315 2.7 
Dec14___18_36_31_Tr_O_B_1-0_Cp_315 1 Yes 315 2.2 
Dec14___18_38_43_Tr_O_C_0-6_Cp_315 0.6 Yes 315 1.5 
Dec14___18_40_44_Tr_O_D_0-7_Cp_315 0.7 Yes 315 1.4 
Dec14___18_42_43_Tr_O_E_1-0_Cp_315 1 Yes 315 2.7 
Dec14___18_58_32_Tr_O_F_1-0_Cp_315 1 Yes 315 1.5 
Dec14___19_0_9_Tr_O_G_1-0_Cp_315 1 Yes 315 2.8 
Dec14___19_25_49_Tr_O_K_0-9_Cp_315 0.9 Yes 315 2.9 
Dec14___19_29_2_Tr_O_L_0-7_Cp_315 0.7 Yes 315 1.5 
Dec14___19_2_52_Tr_O_H_0-9_Cp_315 0.9 Yes 315 1.8 
Dec14___19_34_1_Tr_O_M_1-2_Cp_315 1.2 Yes 315 3.1 
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Dec14___19_42_58_Tr_O_N_1-4_Cp_315 1.4 Yes 315 3.3 
Dec14___19_50_51_Tr_O_O_1-1_Cp_315 1.1 Yes 315 2.6 
Dec14___19_5_38_Tr_O_I_1-2_Cp_315 1.2 Yes 315 3.0 
Dec14___19_7_59_Tr_O_J_1-4_Cp_315 1.4 Yes 315 3.0 
Dec14___20_12_4_Tr_O_P_1-0_Cp_315 1 Yes 315 7.5 
Dec14___20_16_14_Tr_O_Q_0-8_Cp_315 0.8 Yes 315 8.8 
Dec14___20_20_31_Tr_O_R_0-7_Cp_315 0.7 Yes 315 10.1 
Dec14___20_26_18_Tr_O_S_0-8_Cp_315 0.8 Yes 315 10.7 
Dec14___20_29_30_Tr_O_T_0-9_Cp_315 0.9 Yes 315 11.2 
Nov29___17_35_22_Tr_O_2G_1-4_Nc_0 1.4 None 0 5.1 
Nov29___17_40_2_Tr_O_2H_0-8_Nc_0 0.8 None 0 5.1 
Nov29___17_43_11_Tr_O_2I_0-8_Nc_0_Note 0.8 None 0 2.8 
Nov29___17_57_3_Tr_O_2J_1-3_Nc_0_Note 1.3 None 0 7.0 
Nov29___18_0_16_Tr_O_2K_1-3_Nc_0 1.3 None 0 2.7 
Nov29___18_10_15_Tr_O_2L_1-2_Nc_0_Note 1.2 None 0 2.5 
Nov29___18_35_8_Tr_O_3D_0-9_Nc_0 0.9 None 0 7.4 
Nov29___18_39_59_Tr_O_3E_0-9_Nc_0 0.9 None 0 4.3 
Nov29___18_42_50_Tr_O_3F_0-8_Nc_0 0.8 None 0 4.7 
Nov29___19_09_39_Tr_O_3J_0-8_Nc_0 0.8 None 0 4.0 
Nov29___19_12_17_Tr_O_3K_1-1_Nc_0 1.1 None 0 2.3 
Nov29___19_14_56_Tr_O_3L_0-7_Nc_0 0.7 None 0 2.0 
Nov29___16_45_30_Tr_O_2A_1-1_Nc_30_Note 1.1 None 30 13.4 
Nov29___16_48_58_Tr_O_2B_1-0_Nc_30_Note 1 None 30 11.4 
Nov29___16_55_36_Tr_O_2C_1-0_Nc_30_Note 1 None 30 7.1 
Nov29___15_45_57_Tr_O_1B_x_Nc_55 x None 55 7.1 
Nov29___16_7_31_Tr_O_1F_x_Nc_70_COL_Note x None 70 16.0 
Nov29___15_57_15_Tr_O_1D_x_Nc_75_COL_Not
e 
x None 75 23.8 
Nov29___16_4_19_Tr_O_1E_x_Nc_80 x None 80 15.2 
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Appendix 3: Auxiliary Test Data 
Unit Force 
(N/mm2) 
3
2
.8
 
3
1
.7
 
2
7
.2
 
1
.1
 
1
.4
 
0
.9
 
1
.0
 
1
.5
 
1
.5
 
1 CONSECUTIVE 
PTS 
5
.9
 
5
.7
 
4
.9
 
5
.6
 
7
.1
 
4
.6
 
4
.9
 
7
.4
 
7
.7
 
SUTURE TYPE 
V
 
V
 
V
 
V
 
V
 
V
 
V
 
V
 
V
 
Surface Area 
0
.1
8
 
0
.1
8
 
0
.1
8
 
5
.1
 
5
.1
 
5
.1
 
5
.1
 
5
.1
 
5
.1
 
SUTURE SIZE 
3
-0
 
3
-0
 
3
-0
 
1
 
1
 
1
 
1
 
1
 
1
 
Diameter 
0
.0
1
8
 
0
.0
1
8
 
0
.0
1
8
 
0
.5
1
 
0
.5
1
 
0
.5
1
 
0
.5
1
 
0
.5
1
 
0
.5
1
 
T
E
S
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N
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9
_
_
_
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_
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_
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Appendix 4: PubMed Search Criteria & Results 
SEARCH CRITERIA: 
(((((“sutures”[MeSH Terms] OR “sutures”[All Fields] OR “suture”[All Fields]) AND 
(break[All Fields] OR failure[All Fields]) AND English[lang])) NOT technique)) AND 
mechanical 
SAMPLE RESULTS: 
1: Roth B, Birkhäuser FD, Thalmann GN, Zehnder P. Novel prototype sewing device,  
EndoSew(®) , for minimally invasive surgery: an extracorporeal ileal conduit 
construction pilot study in 10 patients. BJU Int. 2013 Mar 15. Doi: 
10.1111/j.1464-410X.2012.11599.x. [Epub ahead of print] PubMed PMID: 23496430. 
 
 
2: Zhang Y, Tran RT, Qattan IS, Tsai YT, Tang L, Liu C, Yang J. Fluorescence 
imaging enabled urethane-doped citrate-based biodegradable elastomers. 
Biomaterials. 2013 May;34(16):4048-56. Doi: 10.1016/j.biomaterials.2013.02.040. 
Epub 2013 Mar 5. PubMed PMID: 23465824. 
 
 
3: Niehaus AJ, Anderson DE, Johnson JK, Lannutti JJ. Comparison of the mechanical 
characteristics of polymerized caprolactam and monofilament nylon loops 
constructed in parallel strands or as braided ropes versus cranial cruciate 
ligaments of cattle. Am J Vet Res. 2013 Mar;74(3):381-5. Doi: 
10.2460/ajvr.74.3.381. PubMed PMID: 23438112. 
 
 
4: Chalmers PN, Hammond LJ, Juhan T, Romeo AA. Revision posterior shoulder 
stabilization. J Shoulder Elbow Surg. 2013 Feb 15. Doi:pii: 
S1058-2746(12)00545-9. 10.1016/j.jse.2012.11.019. [Epub ahead of print] PubMed 
PMID: 23415816. 
 
 
5: Maloul A, Fialkov J, Whyne CM. Characterization of the bending strength of 
craniofacial sutures. J Biomech. 2013 Mar 15;46(5):912-7. Doi: 
10.1016/j.jbiomech.2012.12.016. Epub 2013 Jan 23. PubMed PMID: 23352773. 
 
 
6: Hapa O, Akşahin E, Erduran M, Davul S, Havitçioğlu H, Laprade RF, Bozdağ E, 
Sünbüloğlu E. The influence of suture material on the strength of horizontal 
mattress suture configuration for meniscus repair. Knee. 2013 Jan 19. Doi:pii: 
  67 
S0968-0160(12)00232-3. 10.1016/j.knee.2012.11.010. [Epub ahead of print] PubMed 
PMID: 23340094. 
 
 
7: Borowsky KA, Raghu Prasad V, Wear LJ, Stevenson TE, Trent ND, Bennett AJ, 
Marsden NJ. Is failure of tuberosity suture repair in hemi-arthroplasty for 
fracture mechanical? J Shoulder Elbow Surg. 2013 Jan 18. Doi:pii: 
S1058-2746(12)00404-1. 10.1016/j.jse.2012.09.002. [Epub ahead of print] PubMed 
PMID: 23333733. 
 
 
8: Roos MW, Wadbro E, Berggren M. Computational estimation of fluid mechanical 
benefits from a fluid deflector at the distal end of artificial vascular grafts.  
Comput Biol Med. 2013 Feb 1;43(2):164-8. Doi: 10.1016/j.compbiomed.2012.11.012. 
Epub 2012 Dec 20. PubMed PMID: 23260571. 
 
 
9: Magwene PM, Socha JJ. Biomechanics of turtle shells: how whole shells fail in  
compression. J Exp Zool A Ecol Genet Physiol. 2013 Feb;319(2):86-98. Doi: 
10.1002/jez.1773. Epub 2012 Nov 30. PubMed PMID: 23203474. 
 
 
10: Jha S, Kowaleski MP. Mechanical analysis of twelve toggle suture constructs 
for stabilization of coxofemoral luxations. Vet Surg. 2012 Nov;41(8):948-53. Doi: 
10.1111/j.1532-950X.2012.01028.x. PubMed PMID: 23198922 
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Appendix 5: Suture Material Strength 
 
A
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r 
1
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t  
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a
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a
l 
S
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T
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a
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n
t 
S
o
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ti
o
n
 
E
n
v
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o
n
m
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n
t 
Tensile Strength (Newtons) 
at 
Specified Length of Exposure 
B
e
fo
re
 
T
re
a
tm
e
n
t 
1
 d
a
y
 
5
 d
a
y
s
 
1
 w
e
e
k
 
2
 w
e
e
k
s
 
3
 w
e
e
k
s
 
4
 w
e
e
k
s
 
8
 w
e
e
k
s
 
2010 Karabulut Bio-Syn 5-0 Natural Rat stomach 3.1 
 
3.2 
     
2010 Karabulut Bio-Syn 5-0 Natural Rat intestine 3.1 
 
2.9 
     
2010 Karabulut Bio-Syn 5-0 Natural Rat bile duct 3.1 
 
2.4 
     
2010 Karabulut Bio-Syn 5-0 Natural Rat vesica 3.1 
 
0.2 
     
2010 Karabulut Bio-Syn 5-0 pH 10 in vitro 3.1 
 
0.0 
     
2010 Karabulut Bio-Syn 5-0 pH 1  in vitro 3.1 
 
0.0 
     
2010 Karabulut Bio-Syn 5-0 Rat urine in vitro 3.1 
 
0.0 
     
2010 Karabulut Bio-Syn 5-0 Rat bile in vitro 3.1 
 
1.6 
     
2009 Chung Bio-Syn 
 
Sterile urine in vitro 48.0 39.0 
 
29.0 24.5 
 
23.0 
 
2009 Chung Bio-Syn 
 
E coli inoculated 
media 
in vitro 48.0 
  
28.0 
    
2009 Chung Bio-Syn 
 
P mirabilis inoculated 
media (pH = 7.8) 
in vitro 48.0 
  
28.0 
    
2009 Chung Bio-Syn 
 
Acidic media (pH = 
5.6) 
in vitro 48.0 
  
28.0 
    
2007 Freudenberg 
Biosyn (polyglycolide-
cotrimethylene 
carbonate-codioxanone) 
4-0 
Mean of 8 different 
treatment solutions 
in vitro 30.0 
  
26.0 21.0 10.0 
  
2010 Karabulut Caprosyn 5-0 Natural Rat stomach 2.4 
 
1.6 
     
2010 Karabulut Caprosyn 5-0 Natural Rat intestine 2.4 
 
1.5 
     
2010 Karabulut Caprosyn 5-0 Natural Rat bile duct 2.4 
 
1.0 
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2010 Karabulut Caprosyn 5-0 Natural Rat vesica 2.4 
 
0.7 
     
2010 Karabulut Caprosyn 5-0 pH 10 in vitro 2.4 
 
0.0 
     
2010 Karabulut Caprosyn 5-0 pH 1  in vitro 2.4 
 
0.0 
     
2010 Karabulut Caprosyn 5-0 Rat urine in vitro 2.4 
 
0.0 
     
2010 Karabulut Caprosyn 5-0 Rat bile in vitro 2.4 
 
1.1 
     
2009 Chung Caprosyn 
 
Sterile urine in vitro 60.0 47.5 
 
36.5 30.0 
 
31.5 
 
2009 Chung Caprosyn 
 
E coli inoculated 
media 
in vitro 60.0 
   
32.0 
   
2009 Chung Caprosyn 
 
P mirabilis inoculated 
media (pH = 7.8) 
in vitro 60.0 
   
32.0 
   
2009 Chung Caprosyn 
 
Acidic media (pH = 
5.6) 
in vitro 60.0 
   
60.0 
   
2007 Kim Catgut 4-0 
37°C Hank’s 
balanced salt solution 
in vitro 0.5 1.2 1.7 0.6 0.5 
   
2004 Muftuoglu Catgut 4-0 
human pancreatic 
juice 
in vitro 11.2 0.0 
 
0.0 
    
2004 Muftuoglu Catgut 4-0 human bile in vitro 11.2 6.1 
 
0.0 
    
2004 Muftuoglu Catgut 4-0 
50% human 
pancreatic juice & 
50% human bile 
in vitro 11.2 0.0 
 
0.0 
    
2010 Karabulut Catgut 5-0 Natural Rat stomach 2.6 
 
0.0 
     
2010 Karabulut Catgut 5-0 Natural Rat intestine 2.6 
 
0.4 
     
2010 Karabulut Catgut 5-0 Natural Rat bile duct 2.6 
 
0.3 
     
2010 Karabulut Catgut 5-0 Natural Rat vesica 2.6 
 
0.2 
     
2010 Karabulut Catgut 5-0 pH 10 in vitro 2.6 
 
0.0 
     
2010 Karabulut Catgut 5-0 pH 1  in vitro 2.6 
 
0.0 
     
2010 Karabulut Catgut 5-0 Rat urine in vitro 2.6 
 
0.9 
     
2010 Karabulut Catgut 5-0 Rat bile in vitro 2.6 
 
1.1 
     
2007 Kim Chromic catgut 4-0 
37°C Hank’s 
balanced salt solution 
in vitro 1.1 1.3 2.0 0.9 1.3 
   
2004 Muftuoglu Chromic catgut 4-0 
human pancreatic 
juice 
in vitro 12.3 0.0 
 
0.0 
    
2004 Muftuoglu Chromic catgut 4-0 human bile in vitro 12.3 9.2 
 
5.4 
    
2004 Muftuoglu Chromic catgut 4-0 
50% human 
pancreatic juice & 
50% human bile 
in vitro 12.3 0.0 
 
0.0 
    
2009 Chung Chromic catgut 
 
Sterile urine in vitro 40.0 39.0 
 
38.0 36.0 
 
35.0 
 
2009 Chung Chromic catgut 
 
E coli inoculated urine in vitro 40.0 
     
30.0 
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2009 Chung Chromic catgut 
 
P mirabilis inoculated 
urine (pH = 7.8) 
in vitro 40.0 
     
30.0 
 
2009 Chung Chromic catgut 
 
Acidic urine (pH = 
5.6) 
in vitro 40.0 
     
30.0 
 
2007 Freudenberg Dexon (polyglycolide) 4-0 
Mean of 8 different 
treatment solutions 
in vitro 23.0 
  
22.0 18.0 12.0 
  
2010 Najibi Ethibond Excel 0 None N/A 73.0 
       
2010 Najibi Ethibond Excel 1 None N/A 118.0 
       
2010 Najibi Ethibond Excel 2 None N/A 134.0 
       
2010 Najibi Ethibond Excel 5 None N/A 247.0 
       
2010 Najibi FiberWire 2 None N/A 282.0 
       
2010 Najibi FiberWire 5 None N/A 620.0 
       
2004 Greenberg Glycomer 631 3-0 
Sterile neutral dog 
urine 
in vitro 
 
27.8 
 
21.1 16.8 
 
4.5 
 
2004 Greenberg Glycomer 631 3-0 
Sterile acidic dog 
urine 
in vitro 
 
26.7 
 
26.0 10.1 
 
1.4 
 
2004 Greenberg Glycomer 631 3-0 
Sterile basic 
inoculated dog urine 
in vitro 
 
25.3 
 
10.1 4.6 
 
0.0 
 
2004 Greenberg Glycomer 631 3-0 
Escherichia coli 
inoculated dog urine 
in vitro 
 
26.9 
 
20.0 11.6 
 
2.5 
 
2004 Greenberg Glycomer 631 3-0 
Proteus mirabilis dog 
urine 
in vitro 
 
26.2 
 
5.1 0.0 
 
0.0 
 
2007 Freudenberg 
Maxon (polyglycolide-
cotrimethylene 
carbonate) 
4-0 
Mean of 8 different 
treatment solutions 
in vitro 32.8 
  
28.0 26.0 24.0 
  
2007 Kim Nylon 4-0 
37°C Hank’s 
balanced salt solution 
in vitro 1.6 
       
2004 Muftuoglu Polydioxanone 4-0 
human pancreatic 
juice 
in vitro 12.6 12.6 
 
11.3 
    
2004 Muftuoglu Polydioxanone 4-0 human bile in vitro 12.6 12.6 
 
11.6 
    
2004 Muftuoglu Polydioxanone 4-0 
50% human 
pancreatic juice & 
50% human bile 
in vitro 12.6 12.4 
 
11.8 
    
2002 Makela Polydioxanone (PDS) 1 
phosphate-buffered 
distilled water, pH 7.4, 
at 37° C 
in vitro 58.1 
  
63.6 66.0 64.0 62.5 41.8 
2004 Greenberg Polydioxanone (PDS) 3-0 
Sterile neutral dog 
urine 
in vitro 
 
24.2 
 
20.0 19.8 
 
19.8 
 
2004 Greenberg Polydioxanone (PDS) 3-0 
Sterile acidic dog 
urine 
in vitro 
 
22.8 
 
22.7 19.5 
 
19.8 
 
2004 Greenberg Polydioxanone (PDS) 3-0 
Sterile basic 
inoculated dog urine 
in vitro 
 
23.9 
 
20.1 11.9 
 
0.0 
 
2004 Greenberg Polydioxanone (PDS) 3-0 
Escherichia coli 
inoculated dog urine 
in vitro 
 
24.6 
 
21.3 19.1 
 
18.6 
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2004 Greenberg Polydioxanone (PDS) 3-0 
Proteus mirabilis dog 
urine 
in vitro 
 
23.5 
 
12.2 0.0 
 
0.0 
 
2002 Makela Polydioxanone (PDS) 3-0 
phosphate-buffered 
distilled water, pH 7.4, 
at 37° C 
in vitro 25.3 
  
28.4 28.1 28.3 27.4 8.0 
2010 de la Puerta 
Polydioxanone (PDS) - 
Ethicon 
2-0 Porcine serum in vitro 52.5 50.0 
 
42.8 43.6 44.0 39.7 
 
2010 de la Puerta 
Polydioxanone (PDS) - 
Huaiyin 
2-0 Porcine serum in vitro 61.2 57.3 
 
54.3 46.5 47.9 43.9 
 
2011 Tanaka 
Polydioxanone (PDS) 
(absorbable 
monofilament suture) 
3-
0? 
Saline Rat back 21.5 
  
16.3 18.0 
 
15.6 9.1 
2011 Tanaka 
Polydioxanone (PDS) 
(absorbable 
monofilament suture) 
3-
0? 
E. coli ATCC25922 
and B. fragilis 
ATCC25285 
Rat back 21.5 
  
15.4 15.3 
 
13.5 9.5 
2007 Freudenberg 
Polydioxanone (PDS) 
(absorbable 
monofilament suture) 
4-0 
Mean of 8 different 
treatment solutions 
in vitro 19.5 
  
17.0 15.5 14.0 
  
2007 Kim Polyester 4-0 
37°C Hank’s 
balanced salt solution 
in vitro 1.0 
       
2004 Muftuoglu Polyglactin 910 4-0 
human pancreatic 
juice 
in vitro 13.6 13.2 
 
0.0 
    
2004 Muftuoglu Polyglactin 910 4-0 human bile in vitro 13.6 12.8 
 
5.1 
    
2004 Muftuoglu Polyglactin 910 4-0 
50% human 
pancreatic juice & 
50% human bile 
in vitro 13.6 13.0 
 
2.9 
    
2010 de la Puerta Polyglactin 910 - Huaiyin 2-0 Porcine serum in vitro 64.4 65.5 
 
44.6 31.1 7.4 2.1 
 
2010 Najibi polyglactin 910 (Vicryl) 0 None N/A 105.0 
       
2010 Najibi polyglactin 910 (Vicryl) 1 None N/A 130.0 
       
2010 Najibi polyglactin 910 (Vicryl) 2-0 None N/A 76.0 
       
2007 Freudenberg polyglactin 910 (Vicryl) 4-0 
Mean of 8 different 
treatment solutions 
in vitro 29.5 
  
25.0 21.0 14.0 
  
2010 Karabulut polyglactin 910 (Vicryl) 5-0 Natural Rat stomach 5.3 
 
4.6 
     
2010 Karabulut polyglactin 910 (Vicryl) 5-0 Natural Rat intestine 5.3 
 
4.2 
     
2010 Karabulut polyglactin 910 (Vicryl) 5-0 Natural Rat bile duct 5.3 
 
4.1 
     
2010 Karabulut polyglactin 910 (Vicryl) 5-0 Natural Rat vesica 5.3 
 
4.8 
     
2010 Karabulut polyglactin 910 (Vicryl) 5-0 pH 10 in vitro 5.3 
 
0.0 
     
2010 Karabulut polyglactin 910 (Vicryl) 5-0 pH 1  in vitro 5.3 
 
0.0 
     
2010 Karabulut polyglactin 910 (Vicryl) 5-0 Rat urine in vitro 5.3 
 
4.2 
     
2010 Karabulut Polyglactin 910 (Vicryl) 5-0 Rat bile in vitro 5.3 
 
2.7 
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2009 Chung polyglactin 910 (Vicryl) 
 
Sterile urine in vitro 37.5 37.5 
 
37.0 37.0 
 
38.0 
 
2009 Chung polyglactin 910 (Vicryl) 
 
E coli inoculated 
media 
in vitro 37.5 
   
35.5 
   
2009 Chung polyglactin 910 (Vicryl) 
 
P mirabilis inoculated 
media (pH = 7.8) 
in vitro 37.5 
   
35.5 
   
2009 Chung polyglactin 910 (Vicryl) 
 
Acidic media (pH = 
5.6) 
in vitro 37.5 
   
35.5 
   
2010 de la Puerta 
polyglactin 910 (Vicryl) - 
Ethicon 
2-0 Porcine serum in vitro 75.9 75.6 
 
59.3 43.5 24.2 12.4 
 
2011 Tanaka 
polyglactin 910 (Vicryl) 
(absorbable multifilament 
suture) 
3-
0? 
Saline Rat back 22.4 
  
20.3 17.0 
 
10.9 4.6 
2011 Tanaka 
polyglactin 910 (Vicryl) 
(absorbable multifilament 
suture) 
3-
0? 
E. coli ATCC25922 
and B. fragilis 
ATCC25285 
Rat back 22.4 
  
19.8 15.0 
 
12.2 7.6 
2007 Kim Polyglcolic acid 4-0 
37°C Hank’s 
balanced salt solution 
in vitro 1.5 0.5 1.5 1.6 1.2 
   
2004 Greenberg Polyglecaprone 3-0 
Sterile neutral dog 
urine 
in vitro 
 
27.1 
 
15.7 3.0 
 
3.3 
 
2004 Greenberg Polyglecaprone 3-0 
Sterile acidic dog 
urine 
in vitro 
 
27.4 
 
24.1 9.0 
 
0.0 
 
2004 Greenberg Polyglecaprone 3-0 
Sterile basic 
inoculated dog urine 
in vitro 
 
25.9 
 
8.6 1.8 
 
0.0 
 
2004 Greenberg Polyglecaprone 3-0 
Escherichia coli 
inoculated dog urine 
in vitro 
 
27.6 
 
14.5 4.1 
 
0.0 
 
2004 Greenberg Polyglecaprone 3-0 
Proteus mirabilis dog 
urine 
in vitro 
 
26.2 
 
2.3 0.0 
 
0.0 
 
2010 de la Puerta 
Polyglecaprone 25 - 
Ethicon 
2-0 Porcine serum in vitro 87.8 84.2 
 
51.2 24.7 5.9 5.2 
 
2010 de la Puerta 
Polyglecaprone 25 - 
Huaiyin 
2-0 Porcine serum in vitro 62.8 59.9 
 
39.8 24.6 10.0 5.4 
 
2007 Freudenberg 
Polyglecaprone 25 
(Monocryl) 
4-0 
Mean of 8 different 
treatment solutions 
in vitro 25.0 
  
20.5 15.0 3.0 
  
2004 Muftuoglu Polyglycolic acid 4-0 
human pancreatic 
juice 
in vitro 13.2 12.8 
 
0.0 
    
2004 Muftuoglu Polyglycolic acid 4-0 human bile in vitro 13.2 13.1 
 
4.2 
    
2004 Muftuoglu Polyglycolic acid 4-0 
50% human 
pancreatic juice & 
50% human bile 
in vitro 13.2 12.9 
 
0.0 
    
2002 Makela Polyglyconate (Maxon) 1 
phosphate-buffered 
distilled water, pH 7.4, 
at 37° C 
in vitro 39.1 
  
65.2 71.3 67.7 67.8 26.9 
2004 Greenberg Polyglyconate (Maxon) 3-0 
Sterile neutral dog 
urine 
in vitro 
 
27.4 
 
27.1 22.2 
 
4.0 
 
2004 Greenberg Polyglyconate (Maxon) 3-0 
Sterile acidic dog 
urine 
in vitro 
 
28.7 
 
31.0 24.3 
 
12.6 
 
2004 Greenberg Polyglyconate (Maxon) 3-0 
Sterile basic 
inoculated dog urine 
in vitro 
 
26.8 
 
16.8 6.8 
 
2.2 
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2004 Greenberg Polyglyconate (Maxon) 3-0 
Escherichia coli 
inoculated dog urine 
in vitro 
 
27.3 
 
26.0 16.5 
 
3.3 
 
2004 Greenberg Polyglyconate (Maxon) 3-0 
Proteus mirabilis dog 
urine 
in vitro 
 
27.6 
 
1.3 0.0 
 
0.0 
 
2002 Makela Polyglyconate (Maxon) 3-0 
phosphate-buffered 
distilled water, pH 7.4, 
at 37° C 
in vitro 25.7 
  
30.3 11.9 9.0 5.2 0.0 
2010 Karabulut Polyglyconate (Maxon) 5-0 Natural Rat stomach 2.5 
 
2.0 
     
2010 Karabulut Polyglyconate (Maxon) 5-0 Natural Rat intestine 2.5 
 
2.1 
     
2010 Karabulut Polyglyconate (Maxon) 5-0 Natural Rat bile duct 2.5 
 
2.0 
     
2010 Karabulut Polyglyconate (Maxon) 5-0 Natural Rat vesica 2.5 
 
0.8 
     
2010 Karabulut Polyglyconate (Maxon) 5-0 pH 10 in vitro 2.5 
 
0.0 
     
2010 Karabulut Polyglyconate (Maxon) 5-0 pH 1  in vitro 2.5 
 
0.0 
     
2010 Karabulut Polyglyconate (Maxon) 5-0 Rat urine in vitro 2.5 
 
2.4 
     
2010 Karabulut Polyglyconate (Maxon) 5-0 Rat bile in vitro 2.5 
 
1.4 
     
2009 Chung Polyglyconate (Maxon) 
 
Sterile urine in vitro 50.0 47.5 
 
49.5 48.0 
 
47.0 
 
2009 Chung Polyglyconate (Maxon) 
 
E coli inoculated 
media 
in vitro 50.0 40.0 
 
40.0 40.0 
 
40.0 
 
2009 Chung Polyglyconate (Maxon) 
 
P mirabilis inoculated 
media (pH = 7.8) 
in vitro 50.0 40.0 
 
40.0 40.0 
 
40.0 
 
2009 Chung Polyglyconate (Maxon) 
 
Acidic media (pH = 
5.6) 
in vitro 50.0 40.0 
 
40.0 40.0 
 
40.0 
 
2007 Kim Polypropylene 4-0 
37°C Hank’s 
balanced salt solution 
in vitro 0.5 
       
2004 Muftuoglu Polypropylene 4-0 
human pancreatic 
juice 
in vitro 12.1 12.1 
 
9.4 
    
2004 Muftuoglu Polypropylene 4-0 human bile in vitro 12.1 11.0 
 
10.4 
    
2004 Muftuoglu Polypropylene 4-0 
50% human 
pancreatic juice & 
50% human bile 
in vitro 12.1 10.8 
 
10.2 
    
2010 Karabulut Polypropylene 5-0 Natural Rat stomach 1.3 
 
1.0 
     
2010 Karabulut Polypropylene 5-0 Natural Rat intestine 1.3 
 
1.1 
     
2010 Karabulut Polypropylene 5-0 Natural Rat bile duct 1.3 
 
1.1 
     
2010 Karabulut Polypropylene 5-0 Natural Rat vesica 1.3 
 
1.2 
     
2010 Karabulut Polypropylene 5-0 pH 10 in vitro 1.3 
 
1.3 
     
2010 Karabulut Polypropylene 5-0 pH 1  in vitro 1.3 
 
1.4 
     
2010 Karabulut Polypropylene 5-0 Rat urine in vitro 1.3 
 
1.3 
     
2010 Karabulut Polypropylene 5-0 Rat bile in vitro 1.3 
 
1.2 
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2007 Freudenberg 
Polysorb® (poly l-lactide-
coglycolide) 
4-0 
Mean of 8 different 
treatment solutions 
in vitro 32.8 
  
25.5 19.5 10.0 
  
2011 Tanaka 
Prolene (non-absorbable 
monofilament suture) 
3-
0? 
Saline Rat back 17.7 
  
17.3 16.1 
 
12.7 14.2 
2011 Tanaka 
Prolene (non-absorbable 
monofilament suture) 
3-
0? 
E. coli ATCC25922 
and B. fragilis 
ATCC25285 
Rat back 17.7 
  
17.0 14.5 
 
12.1 12.2 
2007 Freudenberg 
Safil (polyglycolic acid 
polymer) 
4-0 
Mean of 8 different 
treatment solutions 
in vitro 24.0 
  
15.5 12.0 3.0 
  
2007 Kim Silk 4-0 
37°C Hank’s 
balanced salt solution 
in vitro 1.2 
       
2004 Muftuoglu Silk 4-0 
human pancreatic 
juice 
in vitro 9.6 8.8 
 
8.0 
    
2004 Muftuoglu Silk 4-0 human bile in vitro 9.6 9.0 
 
8.6 
    
2004 Muftuoglu Silk 4-0 
50% human 
pancreatic juice & 
50% human bile 
in vitro 9.6 9.1 
 
8.9 
    
2010 Karabulut Silk   5-0 Natural Rat stomach 2.4 
 
2.3 
     
2010 Karabulut Silk   5-0 Natural Rat intestine 2.4 
 
2.5 
     
2010 Karabulut Silk   5-0 Natural Rat bile duct 2.4 
 
1.0 
     
2010 Karabulut Silk   5-0 Natural Rat vesica 2.4 
 
1.8 
     
2010 Karabulut Silk   5-0 pH 10 in vitro 2.4 
 
0.0 
     
2010 Karabulut Silk   5-0 pH 1  in vitro 2.4 
 
0.0 
     
2010 Karabulut Silk   5-0 Rat urine in vitro 2.4 
 
1.5 
     
2010 Karabulut Silk   5-0 Rat bile in vitro 2.4 
 
1.2 
     
2011 Tanaka 
Silk (non-absorbable 
multifilament suture) 
3-
0? 
Saline Rat back 11.9 
  
10.3 9.5 
 
9.2 8.4 
2011 Tanaka 
Silk (non-absorbable 
multifilament suture) 
3-
0? 
E. coli ATCC25922 
and B. fragilis 
ATCC25285 
Rat back 11.9 
  
11.0 9.6 
 
8.8 5.7 
2002 Makela SR-PLLA 1 
phosphate-buffered 
distilled water, pH 7.4, 
at 37° C 
in vitro 58.9 
  
55.4 45.2 54.6 45.9 44.4 
2002 Makela SR-PLLA 3-0 
phosphate-buffered 
distilled water, pH 7.4, 
at 37° C 
in vitro 20.4 
  
21.7 22.1 21.5 22.4 21.9 
2010 Najibi TiCron 2 None N/A 136.0 
       
2010 Najibi TiCron 5 None N/A 226.0 
       
2010 Pillai 
USP Standard for 
Average Minimum 
0 None N/A 14.7 
       
2010 Pillai 
USP Standard for 
Average Minimum 
1 None N/A 17.7 
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2010 Pillai 
USP Standard for 
Average Minimum 
10-
0 
None N/A 0.1 
       
2010 Pillai 
USP Standard for 
Average Minimum 
11-
0 
None N/A 0.1 
       
2010 Pillai 
USP Standard for 
Average Minimum 
2+ None N/A 17.7 
       
2010 Pillai 
USP Standard for 
Average Minimum 
2-0  None N/A 10.8 
       
2010 Pillai 
USP Standard for 
Average Minimum 
3-0   None N/A 6.7 
       
2010 Pillai 
USP Standard for 
Average Minimum 
4-0   None N/A 4.4 
       
2010 Pillai 
USP Standard for 
Average Minimum 
5-0   None N/A 2.3 
       
2010 Pillai 
USP Standard for 
Average Minimum 
6-0   None N/A 1.7 
       
2010 Pillai 
USP Standard for 
Average Minimum 
7-0  None N/A 0.8 
       
2010 Pillai 
USP Standard for 
Average Minimum 
8-0 None N/A 0.5 
       
2010 Pillai 
USP Standard for 
Average Minimum 
9-0  None N/A 0.2 
       
2010 Pillai 
USP Standard for 
Individual Minimum 
0 None N/A 4.4 
       
2010 Pillai 
USP Standard for 
Individual Minimum 
1 None N/A 5.9 
       
2010 Pillai 
USP Standard for 
Individual Minimum 
10-
0 
None N/A 0.1 
       
2010 Pillai 
USP Standard for 
Individual Minimum 
11-
0 
None N/A 0.0 
       
2010 Pillai 
USP Standard for 
Individual Minimum 
2+ None N/A 6.9 
       
2010 Pillai 
USP Standard for 
Individual Minimum 
2-0  None N/A 4.4 
       
2010 Pillai 
USP Standard for 
Individual Minimum 
3-0   None N/A 3.3 
       
2010 Pillai 
USP Standard for 
Individual Minimum 
4-0   None N/A 2.3 
       
2010 Pillai 
USP Standard for 
Individual Minimum 
5-0   None N/A 1.1 
       
2010 Pillai 
USP Standard for 
Individual Minimum 
6-0   None N/A 0.8 
       
2010 Pillai 
USP Standard for 
Individual Minimum 
7-0  None N/A 0.4 
       
2010 Pillai 
USP Standard for 
Individual Minimum 
8-0 None N/A 0.2 
       
2010 Pillai 
USP Standard for 
Individual Minimum 
9-0  None N/A 0.1 
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2007 Freudenberg 
Vicryl® Rapid (poly l-
lactide-coglycolide, 90% 
lycolide/10% l-lactide) 
4-0 
Mean of 8 different 
treatment solutions 
in vitro 18.5 
  
7.0 2.0 0.0 
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Appendix 6: Post-Experiment Processing of Data Files 
Procedure for Post-Processing Files 
Sequence for processing files: 
1. Consolidate files from multiple computers into a single location.  Move any files 
without a complete date – time sequence in the file name to a location outside 
the target directory and any subdirectories; i.e., the target tree. 
2. Use ‘StandardizeDirectoryNames’1 to make file and directory name consistent in 
format. 
3. Use ‘SortFiles2Directories_r2’1 to group files by test. 
4. Identify and move individual test video clips to corresponding test directory.  (This 
is required due to the difference in the time codes of the video clips which can 
differ by the length of the video.  Generally, the clips are in the directory adjacent 
to the test data when the directories are sorted by name.) 
5. Add descriptive titles to directories from lab notes. 
6. Use ‘d_ConvertASCII2xls’1 to generate Excel spreadsheet files. 
7. Use ‘Determine_Tension_at_Failure_Filtered’ to create a spreadsheet containing 
failure (Tear Out) values. 
Use ‘Determine_AUX_Force_Filtered’ to create a spreadsheet containing AUX 
test values. 
Use ‘Determine_Suture_Tension_Filtered’ to create a spreadsheet of suture 
tensions. 
 
                                            
1
 Titles refer to names of custom scripts written specifically for this project. 
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Appendix 7: Software for Data Acquisition 
function StartStopRecordDataGUI 
% GUI for collection and recording of ASCII data from serial port 
% StartStopRecordGUI Starts recording of ASCII data on serial port 
% after a short delay and records collected data 
% when start button is pressed.  
% Stop button stops recording and saves file 
  
   global wt runcount userinfo numericaldata 
   wt = serial('COM16', 'BaudRate', 2400, 'Terminator', 'CR'); 
   runcount = 0; 
   numericaldata(1) = 0; 
   %  Create and then hide the GUI as it is being constructed. 
   guiwindow = figure('Visible','off','Position',[550,130,800,600]); 
  
   %  Construct the components. 
   hStartBut = uicontrol('Style','pushbutton','String','START',... 
          'BackgroundColor', 'Green', ... 
          'Position',[625,300,70,25],... 
          'Callback',{@StartBut_Callback}); 
   hStopBut = uicontrol('Style','pushbutton','String','STOP',... 
          'BackgroundColor', 'Red', ... 
          'Position',[625,360,70,25],... 
          'Callback',{@StopBut_Callback}); 
   userinfo = 'Push START button to begin'; 
   htext = uicontrol('Style','text','String',userinfo,... 
          'Position',[625,250,165,15]); 
   ha = axes('Units','Pixels', 'LineWidth', 2,'Position',[35,125,550,400]);  
   align([hStartBut,hStopBut,htext],'Center','None'); 
    
%    % Create the data to plot. 
%    peaks_data = peaks(35); 
%    membrane_data = membrane; 
%    [x,y] = meshgrid(-8:.5:8); 
%    r = sqrt(x.^2+y.^2) + eps; 
%    sinc_data = sin(r)./r; 
    
   % Initialize the GUI. 
   % Change units to normalized so components resize  
   % automatically. 
   set([guiwindow,ha,hStartBut,hStopBut],... 
        'Units','normalized'); 
   % Assign the GUI a name to appear in the window title. 
   set(guiwindow,'Name','LPN Tension Data Collection','MenuBar', 'none') 
   % Move the GUI to the center of the screen. 
  79 
   %movegui(guiwindow,'center') 
   % Make the GUI visible. 
   set(guiwindow,'Visible','on'); 
  
%% 
% 
%Call back function for pressing "START" 
% 
   function StartBut_Callback(~,~) 
       global measrd run sampletime datalist numpart timestring  
       run = 1; 
       htext = uicontrol('Style','text','String','RUNNING',... 
          'Position',[625,250,165,15]); 
       fopen (wt); 
           mytime = fix(clock);             %Get current time 
           YR = mytime(1);                  %Identify year 
           MO = mytime(2);                  %Identify month 
           DT = mytime(3);                   
           HR = mytime(4); 
           MIN = mytime(5); 
           SEC = mytime(6); 
           timestring = [int2str(YR),'-',int2str(MO),'-', ... 
              int2str(DT),'_',int2str(HR),'_',int2str(MIN),'_', ... 
              int2str(SEC)];                %Compile date / time string for use in file name 
       statusmarker = wt.Status; 
       if (strcmp(statusmarker, 'closed')) 
           htext = uicontrol('Style','text','String','PORT DID NOT OPEN',... 
          'Position',[625,250,165,15]); 
       end 
       while (run == 1) 
           runcount = runcount + 1; 
           fprintf (wt, 'F')                  %Send ASCII 'D' 
           sampletime(runcount, 1:6) = clock; 
           clc; 
           measrd = fscanf(wt)                %Read data from COM port to 'measrd' 
           datalist(runcount, :) = char(measrd(1:9)); %Place reading in table 
           numpart = cat (1, measrd(1:6)); 
           numericaldata(runcount) = str2double(numpart); 
           pause on; 
           pause(0.1); 
           plot(numericaldata, 'LineWidth', 2, 'Marker', 'x'); 
       end 
       htext = uicontrol('Style','text','String','PUSH START TO GET ANOTHER',... 
          'Position',[625,250,165,15]); 
   end 
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%% 
% 
%Call back function for pressing "STOP" 
 
   function StopBut_Callback(~,~) 
           htext = uicontrol('Style','text','String','Stopping',...  
          'Position',[625,250,165,15]);     %Display shutting down message to acknowledge 
button press 
       global  run sampletime datalist timestring 
                                            %Make variable available to other areas 
           run = 0;                         %Setting run to '0' stops loop iterations 
           fclose(wt);                      %Close the serial port            
           filestring1 = ['C:\_Data\TensionData_',timestring,'.csv']; 
           dlmwrite(filestring1, datalist, '-append', 'delimiter', '\t', 'newline', 'pc') 
           filestring2 = ['C:\_Data\DateData_',timestring,'.csv']; 
           dlmwrite(filestring2, sampletime, '-append', 'delimiter', '\t', 'newline', 'pc') 
           saveas(figure(gcf),['C:\_data\Graph',timestring,'.jpg']); %Save display as file 
           runcount = 0; 
           numericaldata = []; 
           datalist = []; 
           sampletime = []; 
           htext = uicontrol('Style','text','String', 'Standby',... 
          'Position',[625,250,165,15]); 
   end 
  
   
  
end 
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Appendix 8: Software for Post Processing 
%% 
%Use to reformat file and directory names to standard format so that  
%sorting by directory name is equivalent to sorting by date/time code.  ANY 
%FILE WHICH DOES NOT INCLUDE A FULL DATE TIME SEQUENCE IN THE NAME 
WILL 
%CAUSE AN ERROR AND SHOULD BE MOVED OUT OF THE TARGET TREE 
BEFORE RUNNING 
%THIS PROGRAM. 
% 
% 
%% 
% 
%   INITIALIZE / CREATE LIST OF FILES TO CONVERT AND DETERMINE QTY 
%   Clear memory 
clear 
%   Enter path were data resides    --- ENDING WITH \ --- 
dworkfolder = cd; 
cd C:\ 
[dapath] = uigetdir; 
cd (dworkfolder) 
filist = dir(fullfile(dapath, '*')); 
loopers = length(filist); 
%% 
%   LOOP TO PROCESS EACH FILE 
%    
% 
loopcntr = 0; 
for loopcntr = 1:loopers; 
%   Find the file name length 
    danamelen = length(filist(loopcntr).name); 
%   Skip non-directories and roots 
    if (~strcmp((filist(loopcntr).name), ('.')) ... 
            && ~strcmp((filist(loopcntr).name), ('..')) ... 
            && ~strcmp((filist(loopcntr).name(danamelen-2:end)), '.db')); 
%     if (filist(loopcntr).isdir == 1) && ~strcmp((filist(loopcntr).name), ('.')) && 
~strcmp((filist(loopcntr).name), ('..')); 
      % Find any spaces and replace with underscore 
        dYr = '2011'; 
%         dStrgIn = strcat(dapath, filist(loopcntr).name); 
        dStrgIn = filist(loopcntr).name; 
        [dBeginOfDate, dYrMoSeprtr, dMoDySeprtr, dEndOfDate] = 
dFuncFindDateStrg(dStrgIn, dYr); 
        dStrgNewChar = '-'; 
        dStrgPos = dYrMoSeprtr; 
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        [dStrgIn] = dFuncReplace1Char(dStrgIn,dStrgPos,dStrgNewChar); 
        dStrgPos = dMoDySeprtr; 
        [dStrgIn] = dFuncReplace1Char(dStrgIn,dStrgPos,dStrgNewChar); 
        dStrgNewChar = '_';         
        [dBeginOfTime, dHrMnSeprtr, dMnSecSeprtr, dEndOfTime] = 
dFuncFindTimeStrg(dStrgIn, dEndOfDate); 
        dStrgPos = dHrMnSeprtr; 
        [dStrgIn] = dFuncReplace1Char(dStrgIn,dStrgPos,dStrgNewChar);         
        dStrgPos = dMnSecSeprtr; 
        [dNewStr] = dFuncReplace1Char(dStrgIn,dStrgPos,dStrgNewChar); 
        dNewFiName = strcat(dNewStr(1:dEndOfDate), '___', 
dNewStr(dBeginOfTime:end)); 
        if isdir(filist(loopcntr).name) 
            mkdir(dapath, dNewFiName); 
            content = dir(fullfile(dapath, filist(loopcntr).name)); 
            if ((length(content) >= 3) ... 
                    && (~strcmp(filist(loopcntr).name, dNewFiName))); 
                movefile((fullfile(dapath, filist(loopcntr).name, '\*.*')), 
(fullfile(dapath,dNewFiName, '\')), 'f') 
                rmdir(strcat(dapath, filist(loopcntr).name)) 
            end 
        elseif (~strcmp(filist(loopcntr).name, dNewFiName)) 
           movefile((fullfile(dapath, filist(loopcntr).name)), (fullfile(dapath,dNewFiName)), 'f') 
        end 
    end 
end 
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%% 
%   SortFiles2Directories_r2 
% 
%   This program is the 2nd step in post-processing data collected using 
%   'StartStopRecordDataGUI'.  Assuming all data and image files are in a 
%   single directory, it prompts the user for the name of that directory 
%   using 'uigetdir'.  A directory is created for each unique date/time 
%   sequence contained in a file name.   
% 
%REMOVE ALL UNUSUAL FILES FROM DIRECTROY.  LEAVE ONLY 
%DATE, TENSION AND SCREEN SHOT FILES. 
% 
%% 
% 
%   INITIALIZE / CREATE LIST OF FILES TO CONVERT AND DETERMINE QTY 
%   Clear memory 
clear 
%% 
%   Determine search criteria 
dworkfolder = cd; 
cd C:\ 
[dapath] = uigetdir; 
cd (dworkfolder) 
filist = dir(fullfile(dapath, '*.*')); 
loopers = length(filist); 
%% 
%   LOOP TO PROCESS EACH FILE 
%    
% 
loopcntr = 0; 
for loopcntr = 1:loopers; 
%   Find the file name length 
    danamelen = length(filist(loopcntr).name); 
%   Skip directories & .db files (thumbnails) 
    if (filist(loopcntr).isdir == 0) && ((strcmpi(filist(loopcntr).name((danamelen - 
2):danamelen), '.db')) == 0); 
%   Find the time code 
         
        daplacecntr = 1; 
        while daplacecntr ~= danamelen;                     %Check each letter in name 
            if filist(loopcntr).name(daplacecntr) == '2';       %When the 1st "2" is found 
                dabegin = daplacecntr;                              %Set location of date begining 
                daplacecntr = danamelen;                            %End search for this file 
            else                                                %If current letter is not a "2" 
                daplacecntr = daplacecntr + 1;                      %Increment the position counter 
            end 
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        end                                                 %Check next letter 
%Need to add code before this point to deal with files which do not have 2 
%in the name. 
% 
%Find the position of the last time code character 
        daplacecntr2 = dabegin + 1;  
        while daplacecntr2 ~= danamelen; 
            if filist(loopcntr).name(daplacecntr2) == '.'; 
                daend = daplacecntr2 - 1; 
                daplacecntr2 = danamelen; 
            else 
                daplacecntr2 = daplacecntr2 + 1; 
            end 
        end 
%   Make sure there is a directory for this time code and move the file 
        dadirectory = filist(loopcntr).name(dabegin:daend); 
        mkdir(dapath, dadirectory); 
        movefile((fullfile(dapath, filist(loopcntr).name)), (fullfile(dapath, dadirectory)), 'f'); 
    end 
end 
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%% 
% 
%   This program processes ASCII data and date files collected by the 
%   'StartStopRecordDataGUI' script AND have already been sorted into 
%   directories by the 'SortFiles2Directories' script. 
% 
%   Functions provided by the program include: 
%       1. Getting search criteria from user GUI 
%       2. Finding files in the specified directory and subdirectories 
%       3. Creating an .xls file in each directory which combines date/time 
%           and data file pairs 
%       4. Creating a summary .xls file in the specified directory which 
%           contains a tab for each date/time and data file pair 
%       5. Creating an error log file which lists file pairs which were not 
%           processed 
clear 
%   Make lists global to pass multiple, variable length lists between 
%   routines. 
global dfilelist dsublist 
dfilelist = struct('name',[], 'date', [], 'bytes', [], 'isdir', [], 'datenum', []); 
dsublist = struct('name',[], 'date', [], 'bytes', [], 'isdir', [], 'datenum', []); 
 
%% 
%   Determine search criteria 
dworkfolder = cd; 
cd C:\ 
[dsublist.name] = uigetdir; 
cd (dworkfolder) 
dcriteria = 'TensionData*.csv'; 
dsubcriteria = '*'; 
%% 
%   Determine files to process 
dFuncFindFiles(dcriteria, dsubcriteria); 
%% 
% 
%   Determine name for day summary file 
[ddayrptname] = dFuncDayRptName; 
% %% 
% %   Initialize spreadsheet communication for day summary 
dfullwkbkname = fullfile((dsublist(1,1).name), ddayrptname); 
[dxlsfile, dexlday] = dFuncInitialzXls(dfullwkbkname); 
%% 
%   Convert ASCII data to xls 
% 
dr6 = size(dfilelist,1); 
derrorctr = 0;              %Initialize error counter 
  86 
derror = cell(1,2);         %Declare derror a cell array 
dheaders = {'DATE', 'TIME', 'FORCE'}; %Specify table headings 
 
for di = 1:dr6 
    %   Format the spreadsheet name 
    dpathandfile = dfilelist(di,1).name; 
    dstartstr = '2012'; 
    doffset = 0; 
    dstr2rm = {'201.-12-'; ... 
                '201.-11-'; ... 
                '201.-10-'; ... 
                '201.-09-'; ... 
                '201.-9-'; ... 
                '201.-08-'; ... 
                '201.-8-'; ... 
                '201.-07-'; ... 
                '201.-7-'; ... 
                '201.-06-'; ... 
                '201.-6-'; ... 
                '201.-05-'; ... 
                '201.-5-'; ... 
                '201.-04-'; ... 
                '201.-4-'; ... 
                '201.-03-'; ... 
                '201.-3-'; ... 
                '201.-02-'; ... 
                '201.-2-'; ... 
                '201.-01-'; ... 
                '201.-1-'}; 
    dstr2plc = {'Dec'; ... 
                'Nov'; ... 
                'Oct'; ... 
                'Sep'; ... 
                'Sep'; ... 
                'Aug'; ... 
                'Aug'; ... 
                'Jul'; ... 
                'Jul'; ... 
                'Jun'; ... 
                'Jun'; ... 
                'May'; ... 
                'May'; ... 
                'Apr'; ... 
                'Apr'; ... 
                'Mar'; ... 
                'Mar'; ... 
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                'Feb'; ... 
                'Feb'; ... 
                'Jan'; ... 
                'Jan'}; 
    [dtestrptname] = dFuncTestRptName(dpathandfile, dstartstr, doffset, dstr2rm, 
dstr2plc); 
    %   Format the individual test Xcel file name 
    [dp,df,dx] = fileparts(dpathandfile); 
    dfiname = fullfile(dp, df); 
    %   Initialize spreadsheet communication for individual test 
    [dtestxlsfile, dexltest] = dFuncInitialzXls(dfiname); 
    %   Calculate the data to be stored in spreadsheets 
    [ddatatable, derrorctr, derror] = dFuncConvrtASCII2xls(dpathandfile, derrorctr, 
derror); 
    %   Write data table to TestRptName file 
    dxlssheet = 1;  %Put on 1st sheet 
    dFuncWriteArray2OpenXLS (ddatatable, dtestxlsfile, dxlssheet, dheaders, 
dtestrptname) 
    %   Terminate communication to individual test report 
    dFuncTerminateXlsCom (dexltest) 
    %   Write data to day report file with each test on new tab 
    dxlssheet = di; 
    dFuncWriteArray2OpenXLS (ddatatable, dxlsfile, dxlssheet, dheaders,dtestrptname) 
end 
%% 
%   Terminate spreadsheet communication to day summary report 
dFuncTerminateXlsCom (dexlday) 
%% 
%   Write error log 
dFuncWriteErLog(derror, dsublist(1).name) 
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%% Determine Tear Out Tension 
% Determine tension by finding highest value repeated the specified number 
% of times in a row.  Creates and Excel spreadsheet with columns for test 
% name, margin, capsule condition, suture angle and each of the specified 
% peak widths. 
% 
%% 
% 
%   INITIALIZE / CREATE LIST OF FILES TO CONVERT AND DETERMINE QTY 
%   Clear memory 
clear all 
%% 
%   Make lists global to pass multiple, variable length lists between 
%   routines. 
dfilelist = struct('name',[], 'date', [], 'bytes', [], 'isdir', [], 'datenum', []); 
dsublist = struct('name',[], 'date', [], 'bytes', [], 'isdir', [], 'datenum', []); 
global dfilelist dsublist 
%% 
%   Determine search criteria 
dworkfolder = cd; 
cd C:\ 
[dsublist.name] = uigetdir; 
cd (dworkfolder) 
% 
%   Enter the number of times value must appear 
dvalfreq = [1, 2, 4, 8, 10]; 
ddatacols = length(dvalfreq); 
% 
%   Enter tolerance for similar values 
dbandwidth = 0.1; 
% 
%   Find tension files & directories 
dcriteria = 'TensionData*.xls'; 
dsubcriteria = '*Tear*'; 
dFuncFindFiles(dcriteria, dsubcriteria) 
 
 
dr6 = size(dfilelist,1); 
derrorctr = 0;              %Initialize error counter 
derror = cell(1,2);         %Declare derror a cell array 
dpeakvalues = cell(1); 
dpeaktable = cell(dr6, (length(dvalfreq)+1)); 
 
 
for di = 1:dr6 
% Make data label 
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    dworkfile = dfilelist(di).name; 
    dstartstr = '2011'; 
    doffset = 0; 
    dstr2rm = {'201.-12-'; ... 
                '201.-11-'; ... 
                '201.-10-'; ... 
                '201.-09-'; ... 
                '201.-9-'; ... 
                '201.-08-'; ... 
                '201.-8-'; ... 
                '201.-07-'; ... 
                '201.-7-'; ... 
                '201.-06-'; ... 
                '201.-6-'; ... 
                '201.-05-'; ... 
                '201.-5-'; ... 
                '201.-04-'; ... 
                '201.-4-'; ... 
                '201.-03-'; ... 
                '201.-3-'; ... 
                '201.-02-'; ... 
                '201.-2-'; ... 
                '201.-01-'; ... 
                '201.-1-'}; 
    dstr2plc = {'Dec'; ... 
                'Nov'; ... 
                'Oct'; ... 
                'Sep'; ... 
                'Sep'; ... 
                'Aug'; ... 
                'Aug'; ... 
                'Jul'; ... 
                'Jul'; ... 
                'Jun'; ... 
                'Jun'; ... 
                'May'; ... 
                'May'; ... 
                'Apr'; ... 
                'Apr'; ... 
                'Mar'; ... 
                'Mar'; ... 
                'Feb'; ... 
                'Feb'; ... 
                'Jan'; ... 
                'Jan'}; 
    [dp, df, dx] = fileparts(dworkfile); 
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    dpathandfile = fullfile(dp, df); 
    [dtestrptname] = dFuncTestRptNameLg(dpathandfile,dstartstr, doffset, dstr2rm, 
dstr2plc); 
    dpeaktable((di),1) = cellstr(dtestrptname); 
%  Get margin 
    dstrgin = dtestrptname; 
    [dmargin] = dFuncGetMargin (dstrgin); 
    dpeaktable((di),2) = cellstr(dmargin); 
%  Get capsule state 
    [dcapcond]= dFuncFindCapCond(dstrgin); 
    dpeaktable((di),3) = cellstr(dcapcond); 
%  Get angle 
    [dangle] = dFuncGetAngle (dstrgin); 
    dpeaktable((di),4) = cellstr(dangle); 
%  Find peak values    
    ddatain = [];                                      % Clear variables used in loop 
    ddatain = xlsread(dworkfile);                      % Read data 
    ddatain = ddatain * (-1);                          %****CORRECTION FOR DIRECTION**** 
    for dk = 1:(length(dvalfreq)) 
        dwinsize = dvalfreq(dk); 
        [dpeakval, dpeakindex] = dFuncFindFlatWindowWithBandWidth (ddatain, dwinsize, 
dbandwidth); 
        dpeaktable((di),(dk+4)) = cellstr(dpeakval); 
    end 
end 
%   Make table headings 
dheaders(1,1) = cellstr('TEST  ID'); 
dheaders(1,2) = cellstr('MARGIN'); 
dheaders(1,3) = cellstr('CAPSULE'); 
dheaders(1,4) = cellstr('ANGLE'); 
for dn = 1:(length(dvalfreq)) 
    dheaders(1,(dn+4)) = cellstr(strcat(num2str(dvalfreq(dn)),' CONSECUTIVE PTS')); 
end 
 
 
%%   WRITE CURRENT DATA SET TO AN EXCEL FILE 
% 
% Make workbook name 
dtempname = dsublist(1).name; 
[p,f,x] = fileparts(dsublist(1).name); 
dwrkbkname = fullfile((dsublist(1).name), strcat(f, '_Tear_Out')); 
[dxlsfile, daexl] = dFuncInitialzXls(dwrkbkname); 
% Open workbook 
dxlsheet = 1; 
dtestrptname = ['AutoCalc_Tension with BW = ', num2str(dbandwidth)]; 
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dFuncWriteArray2OpenXLS_Tension (dpeaktable, dxlsfile, dxlsheet, dheaders, 
dtestrptname, ddatacols) 
dFuncTerminateXlsCom (daexl) 
 
% % % newfiname = strcat(dapath, 'Calcd_Fail_Val_5_Column.xls');     
% % % xlswrite(newfiname, peakval, 'Sheet1', 'A2') 
% % % fihead = {'Test', 'From Notes', '20 Wide', 'Fifeteen Wide', '15 Counts', 'Ten Wide', 
'10 Counts'};  
% % % xlswrite(newfiname, fihead, 'Sheet1', 'A1') 
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%% Determine AUX Test Force 
% Determine tension by finding highest value repeated the specified number 
% of times in a row.  Creates and Excel spreadsheet with columns for test 
% name, margin, capsule condition, suture angle and each of the specified 
% peak widths. 
% 
%% 
% 
%   INITIALIZE / CREATE LIST OF FILES TO CONVERT AND DETERMINE QTY 
%   Clear memory 
clear all 
%% 
%   Make lists global to pass multiple, variable length lists between 
%   routines. 
dfilelist = struct('name',[], 'date', [], 'bytes', [], 'isdir', [], 'datenum', []); 
dsublist = struct('name',[], 'date', [], 'bytes', [], 'isdir', [], 'datenum', []); 
global dfilelist dsublist 
%% 
%   Determine search criteria 
dworkfolder = cd; 
cd C:\ 
[dsublist.name] = uigetdir; 
cd (dworkfolder) 
% 
%   Enter the number of times value must appear 
dvalfreq = [1, 2, 4, 8, 10]; 
ddatacols = length(dvalfreq); 
% 
%   Enter tolerance for similar values 
dbandwidth = 0.2; 
% 
%   Find tension files & directories 
dcriteria = 'TensionData*.xls'; 
dsubcriteria = '*Aux*'; 
dFuncFindFiles(dcriteria, dsubcriteria) 
 
 
dr6 = size(dfilelist,1); 
derrorctr = 0;              %Initialize error counter 
derror = cell(1,2);         %Declare derror a cell array 
dpeakvalues = cell(1); 
dpeaktable = cell(dr6, (ddatacols+1)); 
 
 
for di = 1:dr6 
% Make data label 
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    dworkfile = dfilelist(di).name; 
    dstartstr = '2012'; 
    doffset = 0; 
    dstr2rm = {'201.-12-'; ... 
                '201.-11-'; ... 
                '201.-10-'; ... 
                '201.-09-'; ... 
                '201.-9-'; ... 
                '201.-08-'; ... 
                '201.-8-'; ... 
                '201.-07-'; ... 
                '201.-7-'; ... 
                '201.-06-'; ... 
                '201.-6-'; ... 
                '201.-05-'; ... 
                '201.-5-'; ... 
                '201.-04-'; ... 
                '201.-4-'; ... 
                '201.-03-'; ... 
                '201.-3-'; ... 
                '201.-02-'; ... 
                '201.-2-'; ... 
                '201.-01-'; ... 
                '201.-1-'}; 
    dstr2plc = {'Dec'; ... 
                'Nov'; ... 
                'Oct'; ... 
                'Sep'; ... 
                'Sep'; ... 
                'Aug'; ... 
                'Aug'; ... 
                'Jul'; ... 
                'Jul'; ... 
                'Jun'; ... 
                'Jun'; ... 
                'May'; ... 
                'May'; ... 
                'Apr'; ... 
                'Apr'; ... 
                'Mar'; ... 
                'Mar'; ... 
                'Feb'; ... 
                'Feb'; ... 
                'Jan'; ... 
                'Jan'}; 
    [dp, df, dx] = fileparts(dworkfile); 
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    dpathandfile = fullfile(dp, df); 
    [dtestrptname] = dFuncTestRptNameLg(dpathandfile,dstartstr, doffset, dstr2rm, 
dstr2plc); 
    dpeaktable((di),1) = cellstr(dtestrptname); 
%%  Get suture type 
    dstrgin = dtestrptname; 
    [dsutsize, dsuttype] = dFuncGetSutureInfo(dstrgin); 
    dpeaktable((di),2) = cellstr(dsutsize); 
    dpeaktable((di),3) = cellstr(dsuttype);  
%  Find peak values    
    ddatain = [];                                      % Clear variables used in loop 
    ddatain = xlsread(dworkfile);                      % Read data 
    ddatain = ddatain * (-1);                          %****CORRECTION FOR DIRECTION**** 
    for dk = 1:ddatacols 
        dwinsize = dvalfreq(dk); 
        [dpeakval, dpeakindex] = dFuncFindFlatWindowWithBandWidth (ddatain, dwinsize, 
dbandwidth); 
        dpeaktable((di),(dk+3)) = cellstr(dpeakval); 
    end 
end 
%   Make table headings 
dheaders(1,1) = cellstr('TEST  ID'); 
dheaders(1,2) = cellstr('SUTURE SIZE'); 
dheaders(1,3) = cellstr('SUTURE TYPE'); 
% dheaders(1,4) = cellstr('ANGLE'); 
for dn = 1:ddatacols 
    dheaders(1,(dn+3)) = cellstr(strcat(num2str(dvalfreq(dn)),' CONSECUTIVE PTS')); 
end 
 
 
%%   WRITE CURRENT DATA SET TO AN EXCEL FILE 
% 
% Make workbook name 
dtempname = dsublist(1).name; 
[p,f,x] = fileparts(dsublist(1).name); 
dwrkbkname = fullfile((dsublist(1).name), strcat(f, '_AUX')); 
[dxlsfile, daexl] = dFuncInitialzXls(dwrkbkname); 
% Open workbook 
dxlsheet = 1; 
dtestrptname = ['AutoCalc_Tension with BW = ', num2str(dbandwidth)]; 
dFuncWriteArray2OpenXLS_Tension (dpeaktable, dxlsfile, dxlsheet, dheaders, 
dtestrptname, ddatacols) 
dFuncTerminateXlsCom (daexl) 
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%% Determine Suture Tension 
% Determine tension by finding highest value repeated the specified number 
% of times in a row.  Creates and Excel spreadsheet with columns for test 
% name, perfusion level and each of the specified 
% peak widths. 
% 
%% 
% 
%   INITIALIZE / CREATE LIST OF FILES TO CONVERT AND DETERMINE QTY 
%   Clear memory 
clear all 
%% 
%   Make lists global to pass multiple, variable length lists between 
%   routines. 
global dfilelist dsublist 
dfilelist = struct('name',[], 'date', [], 'bytes', [], 'isdir', [], 'datenum', []); 
dsublist = struct('name',[], 'date', [], 'bytes', [], 'isdir', [], 'datenum', []); 
%% 
%   Determine search criteria 
dworkfolder = cd; 
cd C:\ 
[dsublist.name] = uigetdir; 
cd (dworkfolder) 
% 
%   Enter the number of times value must appear 
dvalfreq = [1, 2, 4, 8, 10]; 
ddatacols = length(dvalfreq); 
% 
%   Enter tolerance for similar values 
dbandwidth = 0.1; 
% 
%   Find tension files & directories 
dcriteria = 'TensionData*.xls'; 
dsubcriteria = '*Tension*'; 
dFuncFindFiles(dcriteria, dsubcriteria) 
 
 
dr6 = size(dfilelist,1); 
derrorctr = 0;              %Initialize error counter 
derror = cell(1,2);         %Declare derror a cell array 
dpeakvalues = cell(1); 
dpeaktable = cell(dr6, (ddatacols+1)); 
 
 
for di = 1:dr6 
% Make data label 
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    dworkfile = dfilelist(di).name; 
    dstartstr = '2012'; 
    doffset = 0; 
    dstr2rm = {'201.-12-'; ... 
                '201.-11-'; ... 
                '201.-10-'; ... 
                '201.-09-'; ... 
                '201.-9-'; ... 
                '201.-08-'; ... 
                '201.-8-'; ... 
                '201.-07-'; ... 
                '201.-7-'; ... 
                '201.-06-'; ... 
                '201.-6-'; ... 
                '201.-05-'; ... 
                '201.-5-'; ... 
                '201.-04-'; ... 
                '201.-4-'; ... 
                '201.-03-'; ... 
                '201.-3-'; ... 
                '201.-02-'; ... 
                '201.-2-'; ... 
                '201.-01-'; ... 
                '201.-1-'}; 
    dstr2plc = {'Dec'; ... 
                'Nov'; ... 
                'Oct'; ... 
                'Sep'; ... 
                'Sep'; ... 
                'Aug'; ... 
                'Aug'; ... 
                'Jul'; ... 
                'Jul'; ... 
                'Jun'; ... 
                'Jun'; ... 
                'May'; ... 
                'May'; ... 
                'Apr'; ... 
                'Apr'; ... 
                'Mar'; ... 
                'Mar'; ... 
                'Feb'; ... 
                'Feb'; ... 
                'Jan'; ... 
                'Jan'}; 
    [dp, df, dx] = fileparts(dworkfile); 
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    dpathandfile = fullfile(dp, df); 
    [dtestrptname] = dFuncTestRptNameLg(dpathandfile,dstartstr, doffset, dstr2rm, 
dstr2plc); 
    dpeaktable((di),1) = cellstr(dtestrptname); 
%  Get perfusion level 
    dstrgin = dworkfile; 
    [dperfusion] = dFuncGetPerfusion (dstrgin); 
    dpeaktable((di),3) = (dperfusion{1,1}); 
%  Find peak values    
    ddatain = [];                                      % Clear variables used in loop 
    ddatain = xlsread(dworkfile);                      % Read data 
    ddatain = ddatain * (-1);                          %****CORRECTION FOR DIRECTION**** 
    for dk = 1:(ddatacols) 
        dwinsize = dvalfreq(dk); 
        [dpeakval, dpeakindex] = dFuncFindFlatWindowWithBandWidth (ddatain, dwinsize, 
dbandwidth); 
        dpeaktable((di),(dk+3)) = cellstr(dpeakval); 
    end 
% Get sample ID 
    [dsampleid] = dFuncGetTestID (dtestrptname, dp); 
    dpeaktable((di),(2)) = cellstr(dsampleid); 
end 
%   Make table headings 
dheaders(1,1) = cellstr('TEST  ID'); 
dheaders(1,3) = cellstr('PERFUSION LEVEL'); 
dheaders(1,2) = cellstr('SAMPLE ID'); 
for dn = 1:(ddatacols) 
    dheaders(1,(dn+3)) = cellstr(strcat(num2str(dvalfreq(dn)),' CONSECUTIVE PTS')); 
end 
 
 
%%   WRITE CURRENT DATA SET TO AN EXCEL FILE 
% 
% Make workbook name 
dtempname = dsublist(1).name; 
[p,f,x] = fileparts(dsublist(1).name); 
dwrkbkname = fullfile((dsublist(1).name), strcat(f, '_Suture_Tension')); 
[dxlsfile, daexl] = dFuncInitialzXls(dwrkbkname); 
% Open workbook 
dxlsheet = 1; 
dtestrptname = ['AutoCalc_Tension with BW = ', num2str(dbandwidth)]; 
dFuncWriteArray2OpenXLS_Tension (dpeaktable, dxlsfile, dxlsheet, dheaders, 
dtestrptname, ddatacols) 
dFuncTerminateXlsCom (daexl) 
 
% % % newfiname = strcat(dapath, 'Calcd_Fail_Val_5_Column.xls');     
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% % % xlswrite(newfiname, peakval, 'Sheet1', 'A2') 
% % % fihead = {'Test', 'From Notes', '20 Wide', 'Fifeteen Wide', '15 Counts', 'Ten Wide', 
'10 Counts'};  
% % % xlswrite(newfiname, fihead, 'Sheet1', 'A1') 
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